NLIGHT, INC. (LASR)
SIC breadcrumb: Manufacturing > Electronic And Other Electrical Equipment And Components, Except Computer Equipment > SIC 3674 Semiconductors & Related Devices
SEC company page: https://www.sec.gov/edgar/browse/?CIK=1124796. Latest filing source: 0001124796-26-000012.
Informational only - descriptive public-record data, not investment advice.
Business
Read LASR's verbatim Item 1 Business section from its latest 10-K: Business.
Risk Factors
Read LASR's verbatim Item 1A Risk Factors from its latest 10-K: Risk Factors.
Selected Fundamentals
| Metric | Value | Unit | FY | Filed |
|---|---|---|---|---|
| Revenue | 261,330,000 | USD | 2025 | 2026-02-27 |
| Net income | -23,467,000 | USD | 2025 | 2026-02-27 |
| Assets | 315,210,000 | USD | 2025 | 2026-02-27 |
Financials
Annual standardized facts from SEC companyfacts as of latest extracted filing date 2026-02-27. Source: https://data.sec.gov/api/xbrl/companyfacts/CIK0001124796.json. Derived margins, ratios, and free cash flow are computed from the extracted annual SEC facts.
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 138,580,000 | 191,359,000 | 176,619,000 | 222,789,000 | 270,146,000 | 242,058,000 | 209,921,000 | 198,548,000 | 261,330,000 | |
| Net income | -14,202,000 | 1,837,000 | 13,938,000 | -12,884,000 | -20,932,000 | -29,669,000 | -54,579,000 | -41,670,000 | -60,792,000 | -23,467,000 |
| Operating income | -9,338,000 | 9,798,000 | 17,063,000 | -9,909,000 | -21,048,000 | -30,217,000 | -55,102,000 | -46,766,000 | -65,636,000 | -26,550,000 |
| Gross profit | 23,166,000 | 44,274,000 | 66,961,000 | 52,339,000 | 59,364,000 | 77,307,000 | 50,821,000 | 46,113,000 | 33,019,000 | 77,963,000 |
| Diluted EPS | -5.68 | 0.00 | 0.32 | -0.35 | -0.55 | -0.70 | -1.23 | -0.90 | -1.27 | -0.47 |
| Operating cash flow | 5,959,000 | 3,411,000 | 3,376,000 | -4,241,000 | 13,041,000 | -7,443,000 | -14,542,000 | 10,091,000 | -2,359,000 | 21,330,000 |
| Capital expenditures | 10,582,000 | 12,403,000 | 23,416,000 | 19,317,000 | 21,388,000 | 5,339,000 | 7,932,000 | 9,032,000 | ||
| Assets | 110,148,000 | 250,130,000 | 249,966,000 | 283,644,000 | 373,618,000 | 329,233,000 | 306,803,000 | 270,241,000 | 315,210,000 | |
| Liabilities | 48,865,000 | 32,347,000 | 33,358,000 | 63,730,000 | 71,485,000 | 58,388,000 | 52,384,000 | 53,811,000 | 88,461,000 | |
| Stockholders' equity | 29,691,000 | 61,283,000 | 217,783,000 | 216,608,000 | 219,914,000 | 302,133,000 | 270,845,000 | 254,419,000 | 216,430,000 | 226,749,000 |
| Cash and cash equivalents | 13,500,000 | 36,687,000 | 149,478,000 | 117,252,000 | 102,282,000 | 146,534,000 | 57,826,000 | 53,210,000 | 65,829,000 | 98,699,000 |
| Free cash flow | -7,206,000 | -16,644,000 | -10,375,000 | -26,760,000 | -35,930,000 | 4,752,000 | -10,291,000 | 12,298,000 |
Ratios
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net margin | 1.33% | 7.28% | -7.29% | -9.40% | -10.98% | -22.55% | -19.85% | -30.62% | -8.98% | |
| Operating margin | 7.07% | 8.92% | -5.61% | -9.45% | -11.19% | -22.76% | -22.28% | -33.06% | -10.16% | |
| Return on equity | -47.83% | 3.00% | 6.40% | -5.95% | -9.52% | -9.82% | -20.15% | -16.38% | -28.09% | -10.35% |
| Return on assets | 1.67% | 5.57% | -5.15% | -7.38% | -7.94% | -16.58% | -13.58% | -22.50% | -7.44% | |
| Liabilities / equity | 0.80 | 0.15 | 0.15 | 0.29 | 0.24 | 0.22 | 0.21 | 0.25 | 0.39 | |
| Current ratio | 2.93 | 9.27 | 7.93 | 4.85 | 6.06 | 6.69 | 6.73 | 5.67 | 3.79 |
Industry Peer Context
Net margin peer context
Operating margin peer context
ROE peer context
ROA peer context
Financial Bridges
Income statement bridge from reported figures
Figure provenance: SEC companyfacts FY 2025. Revenue: accession 0001124796-26-000012; concept RevenueFromContractWithCustomerExcludingAssessedTax; source concepts us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax | Gross profit: accession 0001124796-26-000012; concept GrossProfit; source concepts us-gaap:GrossProfit | Operating income: accession 0001124796-26-000012; concept OperatingIncomeLoss; source concepts us-gaap:OperatingIncomeLoss | Net income: accession 0001124796-26-000012; concept NetIncomeLoss; source concepts us-gaap:NetIncomeLoss
Free cash flow = operating cash flow - capital expenditures
Figure provenance: SEC companyfacts FY 2025. Operating cash flow: accession 0001124796-26-000012; concept NetCashProvidedByUsedInOperatingActivities; source concepts us-gaap:NetCashProvidedByUsedInOperatingActivities | Capital expenditures: accession 0001124796-26-000012; concept PaymentsToAcquirePropertyPlantAndEquipment; source concepts us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | Free cash flow: accession 0001124796-26-000012; concept NetCashProvidedByUsedInOperatingActivities - PaymentsToAcquirePropertyPlantAndEquipment; source concepts us-gaap:NetCashProvidedByUsedInOperatingActivities; us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Financial Charts
Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001124796-26-000012; filed 2026-02-27. Concept: RevenueFromContractWithCustomerExcludingAssessedTax. Source concepts: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001124796-26-000012; filed 2026-02-27. Concept: NetIncomeLoss. Source concepts: us-gaap:NetIncomeLoss.
Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001124796-26-000012; filed 2026-02-27. Concept: OperatingIncomeLoss. Source concepts: us-gaap:OperatingIncomeLoss.
Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001124796-26-000012; filed 2026-02-27. Concept: GrossProfit. Source concepts: us-gaap:GrossProfit.
Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001124796-26-000012; filed 2026-02-27. Concept: EarningsPerShareDiluted. Source concepts: us-gaap:EarningsPerShareDiluted.
Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001124796-26-000012; filed 2026-02-27. Concept: NetCashProvidedByUsedInOperatingActivities. Source concepts: us-gaap:NetCashProvidedByUsedInOperatingActivities.
Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001124796-26-000012; filed 2026-02-27. Concept: PaymentsToAcquirePropertyPlantAndEquipment. Source concepts: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001124796-26-000012; filed 2026-02-27. Concept: Assets. Source concepts: us-gaap:Assets.
Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001124796-26-000012; filed 2026-02-27. Concept: Liabilities. Source concepts: us-gaap:Liabilities.
Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001124796-26-000012; filed 2026-02-27. Concept: StockholdersEquity. Source concepts: us-gaap:StockholdersEquity.
Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001124796-26-000012; filed 2026-02-27. Concept: CashAndCashEquivalentsAtCarryingValue. Source concepts: us-gaap:CashAndCashEquivalentsAtCarryingValue.
Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001124796-26-000012; filed 2026-02-27. Concept: NetCashProvidedByUsedInOperatingActivities - PaymentsToAcquirePropertyPlantAndEquipment. Source concepts: us-gaap:NetCashProvidedByUsedInOperatingActivities; us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
Quarterly
Quarterly standardized facts from SEC companyfacts as of latest extracted filing date 2026-05-08. Source: https://data.sec.gov/api/xbrl/companyfacts/CIK0001124796.json.
| Quarter | End Date | Revenue | Net Income | Diluted EPS | Method |
|---|---|---|---|---|---|
| 2022-Q2 | 2022-06-30 | -0.23 | reported discrete quarter | ||
| 2022-Q3 | 2022-09-30 | -0.29 | reported discrete quarter | ||
| 2023-Q1 | 2023-03-31 | -0.17 | reported discrete quarter | ||
| 2023-Q2 | 2023-06-30 | 53,304,000 | -8,823,000 | -0.19 | reported discrete quarter |
| 2023-Q3 | 2023-09-30 | 50,634,000 | -11,879,000 | -0.26 | reported discrete quarter |
| 2023-Q4 | 2023-12-31 | 51,892,000 | -13,238,000 | derived Q4 = FY annual - nine-month YTD | |
| 2024-Q1 | 2024-03-31 | 44,527,000 | -13,766,000 | -0.29 | reported discrete quarter |
| 2024-Q2 | 2024-06-30 | 50,511,000 | -11,729,000 | -0.25 | reported discrete quarter |
| 2024-Q3 | 2024-09-30 | 56,129,000 | -10,335,000 | -0.21 | reported discrete quarter |
| 2024-Q4 | 2024-12-31 | 47,381,000 | -24,962,000 | derived Q4 = FY annual - nine-month YTD | |
| 2025-Q1 | 2025-03-31 | 51,668,000 | -8,093,000 | -0.16 | reported discrete quarter |
| 2025-Q2 | 2025-06-30 | 61,735,000 | -3,591,000 | -0.07 | reported discrete quarter |
| 2025-Q3 | 2025-09-30 | 66,742,000 | -6,874,000 | -0.14 | reported discrete quarter |
| 2025-Q4 | 2025-12-31 | 81,185,000 | -4,909,000 | derived Q4 = FY annual - nine-month YTD | |
| 2026-Q1 | 2026-03-31 | 80,181,000 | 645,000 | 0.01 | reported discrete quarter |
Quarterly Charts
Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-03-31; accession 0001124796-26-000028; filed 2026-05-08. Concept: RevenueFromContractWithCustomerExcludingAssessedTax. Source concepts: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-03-31; accession 0001124796-26-000028; filed 2026-05-08. Concept: NetIncomeLoss. Source concepts: us-gaap:NetIncomeLoss.
Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-03-31; accession 0001124796-26-000028; filed 2026-05-08. Concept: EarningsPerShareDiluted. Source concepts: us-gaap:EarningsPerShareDiluted.
Macro Cross-References
- CPIAUCSL - Consumer Price Index for All Urban Consumers: All Items in U.S. City Average
- UNRATE - Unemployment Rate
- FEDFUNDS - Federal Funds Effective Rate
- CES0500000003 - Average Hourly Earnings of All Employees, Total Private
- DFEDTARU - Federal Funds Target Range - Upper Limit
- DFEDTARL - Federal Funds Target Range - Lower Limit
- DGS3MO - Market Yield on U.S. Treasury Securities at 3-Month Constant Maturity
- DGS2 - Market Yield on U.S. Treasury Securities at 2-Year Constant Maturity
- DGS10 - Market Yield on U.S. Treasury Securities at 10-Year Constant Maturity
- DGS30 - Market Yield on U.S. Treasury Securities at 30-Year Constant Maturity
- T10Y2Y - 10-Year Treasury Constant Maturity Minus 2-Year Treasury Constant Maturity
- CPILFESL - Consumer Price Index for All Urban Consumers: All Items Less Food and Energy
- CPIUFDSL - Consumer Price Index for All Urban Consumers: Food
- CPIENGSL - Consumer Price Index for All Urban Consumers: Energy
- CUSR0000SAH1 - Consumer Price Index for All Urban Consumers: Shelter
- PCEPI - Personal Consumption Expenditures: Chain-type Price Index
- PCEPILFE - Personal Consumption Expenditures Excluding Food and Energy: Chain-type Price Index
- PPIACO - Producer Price Index by Commodity: All Commodities
- T10YIE - 10-Year Breakeven Inflation Rate
- U6RATE - Total Unemployed, Plus All Marginally Attached Workers Plus Total Employed Part Time for Economic Reasons
- PAYEMS - All Employees, Total Nonfarm
- CIVPART - Labor Force Participation Rate
- EMRATIO - Employment-Population Ratio
- UNEMPLOY - Unemployed
- CE16OV - Employment Level
- ICSA - Initial Claims
- JTSJOL - Job Openings: Total Nonfarm
- JTSQUR - Quits: Total Nonfarm
- GDPC1 - Real Gross Domestic Product
- A191RL1Q225SBEA - Real Gross Domestic Product: Percent Change from Preceding Period
- INDPRO - Industrial Production: Total Index
- TCU - Capacity Utilization: Total Index
- HOUST - New Privately-Owned Housing Units Started: Total Units
- PERMIT - New Privately-Owned Housing Units Authorized in Permit-Issuing Places: Total Units
- RSAFS - Advance Retail Sales: Retail Trade
- PCE - Personal Consumption Expenditures
- DSPIC96 - Real Disposable Personal Income
- PSAVERT - Personal Saving Rate
- M2SL - M2
- BOPGSTB - U.S. International Trade in Goods and Services: Balance
- MSPUS - Median Sales Price of Houses Sold for the United States
- HSN1F - New One Family Houses Sold: United States
- RHORUSQ156N - Homeownership Rate in the United States
- TTLCONS - Total Construction Spending: Total Construction in the United States
- RRVRUSQ156N - Rental Vacancy Rate in the United States
- TOTALSL - Total Consumer Credit Owned and Securitized
- REVOLSL - Revolving Consumer Credit Owned and Securitized
- DRCCLACBS - Delinquency Rate on Credit Card Loans, All Commercial Banks
- GDP - Gross Domestic Product
- GPDI - Gross Private Domestic Investment
- GCE - Government Consumption Expenditures and Gross Investment
- PCEC - Personal Consumption Expenditures
- NETEXP - Net Exports of Goods and Services
- GFDEBTN - Federal Debt: Total Public Debt
- GFDEGDQ188S - Federal Debt: Total Public Debt as Percent of Gross Domestic Product
- FYFSD - Federal Surplus or Deficit
- FGRECPT - Federal Government Current Receipts
- FGEXPND - Federal Government: Current Expenditures
- MANEMP - All Employees, Manufacturing
- USCONS - All Employees, Construction
- USTRADE - All Employees, Retail Trade
- USFIRE - All Employees, Financial Activities
- USGOVT - All Employees, Government
- AWHAETP - Average Weekly Hours of All Employees, Total Private
- DGORDER - Manufacturers' New Orders: Durable Goods
- NEWORDER - Manufacturers' New Orders: Nondefense Capital Goods Excluding Aircraft
- BUSINV - Total Business Inventories
- EXPGS - Exports of Goods and Services
- IMPGS - Imports of Goods and Services
- IR - Import Price Index (End Use): All Commodities
- PPIFIS - Producer Price Index by Commodity: Final Demand
Latest quarter (10-Q)
Latest 10-Q source: 0001124796-26-000028.
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In some cases, you can identify forward-looking statements by the following words: "ability," "anticipate," "attempt," "believe," "can be," "continue," "could," "depend," "enable," "estimate," "expect," "extend," "grow," "if," "intend," "likely," "may," "objective," "ongoing," "plan," "possible," "potential," "predict," "project," "propose," "rely," "should," "target," "will," "would" or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words.
These statements involve risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from the information expressed or implied by these forward-looking statements. Although we believe that we have a reasonable basis for each forward-looking statement, we caution you that these statements are based on a combination of facts and factors currently known by us and our projections of the future, about which we cannot be certain. Forward-looking statements include, but are not limited to, statements about: our business model and strategic plans; our expectations regarding manufacturing; our future financial performance; demand for our semiconductor and fiber laser solutions; our ability to develop innovative products; our expectations regarding product volumes and the introduction of new products; our technology and new product research and development activities; the impact of new import and export controls; the impact of changes in regulations and customs, tariffs and trade barriers, or the perception that any of them could occur; the impact of inflation; the impact of seasonality; the effect on our business of litigation to which we are or may become a party; and the sufficiency of our existing liquidity sources to meet our cash needs.
You should refer to the "Risk Factors" section of this report for a discussion of other important factors that may cause our actual results to differ materially from those expressed or implied by our forward-looking statements. As a result of these factors, we cannot assure you that the forward-looking statements in this report will prove to be accurate. In addition, statements that "we believe" and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based upon information available to us as of the date of this report, which although we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete, and our statements should not be read to indicate that we have conducted a thorough inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain and investors are cautioned not to unduly rely upon these statements. Furthermore, if our forward-looking statements prove to be inaccurate, the inaccuracy may be material. In light of the significant uncertainties in these forward-looking statements, you should not regard these statements as a representation or warranty by us or any other person that we will achieve our objectives and plans in any specified time frame, or at all. We undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
Overview
nLIGHT, Inc. is a leading provider of high‑power lasers for mission-critical directed energy, optical sensing, and advanced manufacturing applications. We design, develop, manufacture, integrate and sell a range of high-power semiconductor lasers and fiber lasers and related components, modules and subsystems that are typically integrated into laser systems or manufacturing tools built by us or our customers. We also make high energy pulsed fiber lasers, fiber amplifiers, and beam combination and control systems for use in high-energy laser systems for directed energy and laser sensing systems for use in a wide range of commercial and defense applications. Our long history of commercial technology development and vertical integration enables us to develop products that leverage the same underlying technology across a variety of applications and markets, thereby enabling us to leverage the development of shared technologies in unique combinations to offer innovative and reliable products to customers in each of our end markets. We sell our products into three primary end markets: Aerospace and Defense, Industrial, and Microfabrication.
We operate in two reportable segments consisting of the Laser Products segment and the Advanced Development segment.
Revenues increased to $80.2 million in the three months ended March 31, 2026 compared to $51.7 million in the same period in 2025 due primarily to an increase in both product and development revenue from the Aerospace and
17
Table of Contents
Defense end market. We generated net income of $0.6 million for the three months ended March 31, 2026 compared to a net loss of $8.1 million for the same period in 2025.
18
Table of Contents
Factors Affecting Our Performance
Demand for our Products and Solutions
Our revenue depends largely on market conditions, competitive pressure, and achievement of design wins. We consider a design win to occur when a customer notifies us that it has selected one of our products to be incorporated into a product or system under development by such customer. In the Aerospace and Defense market, our business also depends in large part on continued investment in laser technology by the U.S. government and its allies, and our ability to continue to successfully develop leading technology in this area and commercialize that technology in the future.
Demand for our products also fluctuates based on market cycles, continuously evolving industry supply chains, trade and tariff terms, as well as evolving competitive dynamics in each of our end-markets. Erosion of ASPs of established products is typical in our industry, and the ASPs of our products generally decrease as our products mature. We may also negotiate discounted selling prices from time to time with certain customers that purchase higher volumes, or to penetrate new markets or applications.
Technology and New Product Development
We invest heavily in the development of our semiconductor, fiber laser, directed energy, and laser-sensing technologies to provide solutions to our current and future customers. We anticipate that we will continue to invest in research and development to achieve our technology and product roadmap. Our product development is targeted to specific sectors of the market where we believe the performance of our products provides a significant benefit to our customers. We believe our close coordination with our customers regarding their future product requirements enhances the efficiency of our research and development expenditures.
Manufacturing Costs and Gross Margins
Product gross profit, in absolute dollars and gross margin, may fluctuate from period to period based on product sales mix, sales volumes, changes in ASPs, production volumes, the corresponding absorption of manufacturing overhead expenses, the cost of purchased materials, production costs and manufacturing yields. Product sales mix can affect gross profits due to variations in profitability related to product configurations and cost profiles, customer volume pricing, availability of competitive products in various markets, and new product introductions, among other factors. Even though certain of our products are built offshore by contract manufacturers, capacity utilization affects gross margin because of the fixed cost associated with our U.S.-based manufacturing capabilities. Change in sales and production volumes impact absorption of fixed costs, manufacturing efficiencies and production costs.
Our Development gross profit varies with the type and terms of contracts, contract volume, project mix, changes in the estimated cost of projects at completion, and successful execution on projects during the period. Most of our Development contracts have historically been structured as cost plus fixed fee due to the technical complexity of the research and development services, but we also perform work under fixed price contracts where gross margin can change from period to period based on the estimated cost of the project at completion.
Seasonality
Our quarterly revenues can fluctuate with general economic trends, the timing of capital expenditures by our customers, holidays, and general economic trends. In addition, as is typical in our industry, we tend to recognize a larger percentage of our quarterly revenues in the last month of the quarter, which may impact our working capital trends.
Global Economic Conditions
A portion of our sales are generated from products manufactured outside the United States and we sell our products globally. Changing trade dynamics, including changes in tariffs and export regulations, could disrupt our supply chain, disrupt customer sales, and increase input costs. We continue to monitor macroeconomic trends, global inflationary pressures, and uncertainties related to international trade policy, including tariff actions and regulatory shifts. For instance, in February 2026, the U.S. Supreme Court issued a ruling invalidating certain tariffs previously imposed under the International Emergency Economic Powers Act (IEEPA). In March 2026, the U.S. Court of International Trade Court issued an additional ruling stating that importers that have paid tariffs under IEEPA are
19
Table of Contents
due refunds. We are currently evaluating the impact of this decision on our business, as the ultimate timing and amount of any potential refunds is uncertain and subject to further legal and regulatory developments.
Changes in global economic conditions and tariffs on goods to and from the U.S. did not have a material impact on our financial results in the three months ended March 31, 2026. However, changes in global economic conditions and uncertainty related to tariffs could increase our operational complexity, and have a negative impact on revenue and profitability in the future.
Results of Operations
The following table sets forth our operating results as a percentage of revenues for the periods indicated (which may not add up due to rounding):
| Three Months Ended March 31, | |||||
|---|---|---|---|---|---|
| 2026 | 2025 | ||||
| Revenue: | |||||
| Products | 72.6 | % | 69.1 | % | |
| Development | 27.4 | 30.9 | |||
| Total revenue | 100.0 | 100.0 | |||
| Cost of revenue: | |||||
| Products | 40.9 | 45.9 | |||
| Development | 26.0 | 27.4 | |||
| Total cost of revenue | 66.9 | 73.3 | |||
| Gross profit | 33.1 | 26.7 | |||
| Operating expenses: | |||||
| Research and development | 14.8 | 22.0 | |||
| Sales, general, and administrative | 18.8 | 23.3 | |||
| Restructuring | 0.4 | — | |||
| Total operating expenses | 34.0 | 45.3 | |||
| Loss from operations | (0.9) | (18.6) | |||
| Other income: | |||||
| Interest income | 1.9 | 3.3 | |||
| Interest expense | (0.4) | (0.1) | |||
| Other income, net | 0.3 | — | |||
| Income (loss) before income taxes | 0.9 | (15.4) | |||
| Income tax expense | 0.1 | 0.3 | |||
| Net income (loss) | 0.8 | % | (15.7) | % |
Revenues by End Market
Our revenues by end market were as follows for the periods presented (dollars in thousands):
[[GREPCENT_TABLE]]
[["","Three Months Ended March 31,","","Change"],["","2026","% of Revenue","","2025","% of Revenue","","$","","%"],["Aerospace and
[Excerpt truncated for page length; source filing is linked above.]
Latest 10-K MD&A
ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
This Annual Report on Form 10-K contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In some cases, you can identify forward-looking statements by the following words: "ability," "anticipate," "attempt," "believe," "can be," "continue," "could," "depend," "enable," "estimate," "expect," "extend," "grow," "if," "intend," "likely," "may,"
23
Table of Contents
"objective," "ongoing," "plan," "possible," "potential," "predict," "project," "propose," "rely," "should," "target," "will," "would" or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words.
These statements involve risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from the information expressed or implied by these forward-looking statements. Although we believe that we have a reasonable basis for each forward-looking statement, we caution you that these statements are based on a combination of facts and factors currently known by us and our projections of the future, about which we cannot be certain. Forward-looking statements include, but are not limited to, statements about: our business model and strategic plans; our expectations regarding manufacturing; our future financial performance; demand for our semiconductor and fiber laser solutions; our ability to develop innovative products; our expectations regarding product volumes and the introduction of new products; our technology and new product research and development activities; the impact of new import and export controls; the impact of changes in regulations and customs, tariffs and trade barriers, or the perception that any of them could occur; the impact of inflation; the impact of seasonality; the effect on our business of litigation to which we are or may become a party; and the sufficiency of our existing liquidity sources to meet our cash needs.
You should refer to the "Risk Factors" section of this report for a discussion of other important factors that may cause our actual results to differ materially from those expressed or implied by our forward-looking statements. As a result of these factors, we cannot assure you that the forward-looking statements in this report will prove to be accurate. In addition, statements that "we believe" and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based upon information available to us as of the date of this report, which although we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete, and our statements should not be read to indicate that we have conducted a thorough inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain and investors are cautioned not to unduly rely upon these statements. Furthermore, if our forward-looking statements prove to be inaccurate, the inaccuracy may be material. In light of the significant uncertainties in these forward-looking statements, you should not regard these statements as a representation or warranty by us or any other person that we will achieve our objectives and plans in any specified time frame, or at all. We undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
Overview
nLIGHT, Inc. is a leading provider of high‑power lasers for mission-critical directed energy, optical sensing, and advanced manufacturing applications. We design, manufacture, and sell a range of high-power semiconductor lasers and fiber lasers that are typically integrated into laser systems or manufacturing tools built by our customers. We also make high energy pulsed fiber lasers, fiber amplifiers, and beam combination and control systems for use in high-energy laser systems for directed energy and laser sensing systems used in a wide range of defense applications. Our vertical integration enables us to develop products that leverage the same underlying technology, thereby enabling us to offer innovative and reliable products to customers in each of our end markets. We sell our products into three primary end markets: Aerospace and Defense, Industrial, and Microfabrication.
We operate in two reportable segments consisting of the Laser Products segment and the Advanced Development segment.
Revenues increased to $261.3 million in the year ended December 31, 2025 compared to $198.5 million in 2024 due to higher sales volumes in the Laser Products segment and continued growth in the Advanced Development segment. We generated a net loss of $23.5 million for the year ended December 31, 2025 compared to a net loss of $60.8 million in 2024.
Factors Affecting Our Performance
Demand for our Products and Solutions
Our revenue depends largely on market conditions, competitive pressure, and achievement of design wins. We consider a design win to occur when a customer notifies us that it has selected one of our products to be incorporated into a product or system under development by such customer. In the Aerospace and Defense market, our business also depends in large part on continued investment in laser technology by the U.S. government and its
24
Table of Contents
allies, and our ability to continue to successfully develop leading technology in this area and commercialize that technology in the future.
Demand for our products also fluctuates based on market cycles, continuously evolving industry supply chains, trade and tariff terms, as well as evolving competitive dynamics in each of our end-markets. Erosion of ASPs of established products is typical in our industry, and the ASPs of our products generally decrease as our products mature. We may also negotiate discounted selling prices from time to time with certain customers that purchase higher volumes, or to penetrate new markets or applications.
Technology and New Product Development
We invest heavily in the development of our semiconductor, fiber laser, directed energy, and laser-sensing technologies to provide solutions to our current and future customers. We anticipate that we will continue to invest in research and development to achieve our technology and product roadmap. Our product development is targeted to specific sectors of the market where we believe the performance of our products provides a significant benefit to our customers. We believe our close coordination with our customers regarding their future product requirements enhances the efficiency of our research and development expenditures.
Manufacturing Costs and Gross Margins
Product gross profit, in absolute dollars and gross margin, may fluctuate from period to period based on product sales mix, sales volumes, changes in ASPs, production volumes, the corresponding absorption of manufacturing overhead expenses, the cost of purchased materials, production costs and manufacturing yields. Product sales mix can affect gross profits due to variations in profitability related to product configurations and cost profiles, customer volume pricing, availability of competitive products in various markets, and new product introductions, among other factors. Even though certain of our products are built offshore by contract manufacturers, capacity utilization affects gross margin because of the fixed cost associated with our U.S.-based manufacturing capabilities. Change in sales and production volumes impact absorption of fixed costs, manufacturing efficiencies and production costs.
Our Development gross profit varies with the type and terms of contracts, contract volume, project mix, changes in the estimated cost of projects at completion, and successful execution on projects during the period. Most of our Development contracts have historically been structured as cost plus fixed fee due to the technical complexity of the research and development services, but we also perform work under fixed price contracts where gross margin can change from period to period based on the estimated cost of the project at completion.
Seasonality
Our quarterly revenues can fluctuate with general economic trends, the timing of capital expenditures by our customers, holidays, and general economic trends. In addition, as is typical in our industry, we tend to recognize a larger percentage of our quarterly revenues in the last month of the quarter, which may impact our working capital trends.
Global Economic Conditions
We continue to monitor macroeconomic trends, global inflationary pressures, and uncertainties related to international trade policy, including tariff actions and regulatory shifts. The U.S. government implemented a new series of tariffs on imported goods during 2025, prompting retaliatory tariffs by other countries.
A portion of our sales are generated from products manufactured outside the United States and we sell our products globally. Changing trade dynamics, including newly imposed or proposed tariffs and export controls, could disrupt our supply chain and increase input costs. These trade policy developments did not have a material impact on our financial results in 2025. However, if current trends continue or intensify, we may experience increased cost volatility, operational complexity, and broader economic pressures on our customer base that could have a negative impact on revenue and profitability in the future.
25
Table of Contents
Results of Operations
The following table sets forth our operating results as a percentage of revenues for the periods indicated (which may not add up due to rounding):
| Year Ended December 31, | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 2024 | 2023 | |||||||||
| Revenue: | |||||||||||
| Products | 68.6 | % | 68.8 | % | 74.6 | % | |||||
| Development | 31.4 | 31.2 | 25.4 | ||||||||
| Total revenue | 100.0 | 100.0 | 100.0 | ||||||||
| Cost of revenue: | |||||||||||
| Products | 42.6 | 54.4 | 54.4 | ||||||||
| Development | 27.6 | 29.0 | 23.6 | ||||||||
| Total cost of revenue | 70.2 | 83.4 | 78.0 | ||||||||
| Gross profit | 29.8 | 16.6 | 22.0 | ||||||||
| Operating expenses: | |||||||||||
| Research and development | 18.4 | 22.7 | 22.0 | ||||||||
| Sales, general and administrative | 20.7 | 24.8 | 21.8 | ||||||||
| Restructuring | 0.9 | 2.2 | 0.4 | ||||||||
| Total operating expenses | 40.0 | 49.7 | 44.2 | ||||||||
| Loss from operations | (10.2) | (33.1) | (22.2) | ||||||||
| Other income (expense): | |||||||||||
| Interest income | 1.9 | 0.9 | 0.5 | ||||||||
| Interest expense | (0.4) | — | — | ||||||||
| Other income, net | — | 1.6 | 1.3 | ||||||||
| Loss before income taxes | (8.7) | (30.6) | (20.4) | ||||||||
| Income tax expense (benefit) | 0.3 | — | (0.5) | ||||||||
| Net loss | (9.0) | % | (30.6) | % | (19.9) | % |
Revenues by End Market
Our revenues by end market were as follows (dollars in thousands):
| Year Ended December 31, | Change | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | % of Revenue | 2024 | % of Revenue | Amount | % | |||||||||||||
| Aerospace and Defense | $ | 175,253 | 67.0 | % | $ | 109,540 | 55.2 | % | $ | 65,713 | 60.0 | % | ||||||
| Microfabrication | 47,230 | 18.1 | 43,393 | 21.8 | 3,837 | 8.8 | ||||||||||||
| Industrial | 38,847 | 14.9 | 45,615 | 23.0 | (6,768) | (14.8) | ||||||||||||
| $ | 261,330 | 100.0 | % | $ | 198,548 | 100.0 | % | $ | 62,782 | 31.6 | % |
| Year Ended December 31, | Change | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | % of Revenue | 2023 | % of Revenue | Amount | % | |||||||||||||
| Aerospace and Defense | $ | 109,540 | 55.2 | % | $ | 91,394 | 43.6 | % | $ | 18,146 | 19.9 | % | ||||||
| Microfabrication | 43,393 | 21.8 | 47,483 | 22.6 | (4,090) | (8.6) | ||||||||||||
| Industrial | 45,615 | 23.0 | 71,044 | 33.8 | (25,429) | (35.8) | ||||||||||||
| $ | 198,548 | 100.0 | % | $ | 209,921 | 100.0 | % | $ | (11,373) | (5.4) | % |
26
Table of Contents
The increase in revenue from the Aerospace and Defense market for 2025 compared to 2024 was driven by increased unit sales of directed energy laser products and progress on existing development contracts. The increase in revenue from the Microfabrication market for 2025 compared to 2024 was primarily attributable to increased unit sales of semiconductor lasers in EMEA and Asia Pacific, partially offset by decreased unit sales in North America. The decrease in revenue from the Industrial market for 2025 compared to 2024 was primarily the result of decreased unit sales of industrial fiber lasers for cutting and welding due to lower customer demand and deteriorating market conditions across all regions.
The increase in revenue from the Aerospace and Defense market for 2024 compared to 2023 was the result of increased unit sales of products due to higher demand, an increase in ASPs, and increased development revenue from development contracts awarded primarily in the second half of 2023. The decrease in revenue from the Microfabrication market for 2024 compared to 2023 was primarily attributable to decreased unit sales of semiconductor lasers in EMEA and Asia Pacific, offset partially by increased unit sales in North America. The decrease in revenue from the Industrial market for 2024 compared to 2023 was primarily the result of decreased unit sales across all regions due to deteriorating market conditions and lower customer demand in cutting and additive manufacturing.
Revenues by Segment
Our revenues by segment were as follows (dollars in thousands):
| Year Ended December 31, | Change | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | % of Revenue | 2024 | % of Revenue | Amount | % | |||||||||||||
| Laser Products | $ | 179,236 | 68.6 | % | $ | 136,659 | 68.8 | % | $ | 42,577 | 31.2 | % | ||||||
| Advanced Development | 82,094 | 31.4 | 61,889 | 31.2 | 20,205 | 32.6 | ||||||||||||
| $ | 261,330 | 100.0 | % | $ | 198,548 | 100.0 | % | $ | 62,782 | 31.6 | % |
| Year Ended December 31, | Change | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | % of Revenue | 2023 | % of Revenue | Amount | % | |||||||||||||
| Laser Products | $ | 136,659 | 68.8 | % | $ | 156,666 | 74.6 | % | $ | (20,007) | (12.8) | % | ||||||
| Advanced Development | 61,889 | 31.2 | 53,255 | 25.4 | 8,634 | 16.2 | ||||||||||||
| $ | 198,548 | 100.0 | % | $ | 209,921 | 100.0 | % | $ | (11,373) | (5.4) | % |
The increase in Laser Products revenue for 2025 compared to 2024 was the result of increased revenue from the Aerospace and Defense market and Microfabrication market as discussed above, partially offset by decreased revenue from the Industrial market. The increase in Advanced Development revenue for 2025 compared to 2024 was driven by progress on existing research and development contracts.
The decrease in Laser Products revenue for 2024 compared to 2023 was driven by decreased revenue from both the Industrial and Microfabrication markets as discussed above, offset partially by increased revenue from the Aerospace and Defense market. The increase in Advanced Development revenue for 2024 compared to 2023 was the result of increased activity on development contracts awarded primarily in the second half of 2023.
All Advanced Development revenue is included in the Aerospace and Defense market.
Revenues by Geographic Region
Our revenues by geographic region were as follows (dollars in thousands):
27
Table of Contents
| Year Ended December 31, | Change | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | % of Revenue | 2024 | % of Revenue | Amount | % | |||||||||||||
| North America | $ | 185,620 | 71.0 | % | $ | 132,812 | 66.9 | % | $ | 52,808 | 39.8 | % | ||||||
| Asia Pacific | 38,422 | 14.7 | 38,137 | 19.2 | 285 | 0.7 | ||||||||||||
| EMEA(1) | 37,288 | 14.3 | 27,599 | 13.9 | 9,689 | 35.1 | ||||||||||||
| $ | 261,330 | 100.0 | % | $ | 198,548 | 100.0 | % | $ | 62,782 | 31.6 | % |
(1) EMEA consists of Europe, the Middle East, and Africa.
| Year Ended December 31, | Change | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | % of Revenue | 2023 | % of Revenue | Amount | % | |||||||||||||
| North America | $ | 132,812 | 66.9 | % | $ | 129,311 | 61.6 | % | $ | 3,501 | 2.7 | % | ||||||
| Asia Pacific | 38,137 | 19.2 | 45,765 | 21.8 | (7,628) | (16.7) | ||||||||||||
| EMEA(1) | 27,599 | 13.9 | 34,845 | 16.6 | (7,246) | (20.8) | ||||||||||||
| $ | 198,548 | 100.0 | % | $ | 209,921 | 100.0 | % | $ | (11,373) | (5.4) | % |
(1) EMEA consists of Europe, the Middle East, and Africa.
Geographic revenue information is based on the location to which we deliver our products and services.
The increase in North America revenue for 2025 compared to 2024 was the result of increased revenue from the Aerospace and Defense market, partially offset by decreased revenue from the Microfabrication and Industrial markets. The increases in Asia Pacific and EMEA revenues for 2025 compared to 2024 were the result of increased revenue from the Aerospace and Defense market and Microfabrication market, partially offset by decreased revenue from the Industrial market.
The increase in North America revenue for 2024 compared to 2023 was the result of increased revenue from the Aerospace and Defense market and Microfabrication market, partially offset by decreased revenue from the Industrial market. The decrease in Asia Pacific revenue for 2024 compared to 2023 was the result of decreased revenue from all end markets. The decrease in EMEA revenue for 2024 compared to 2023 was the result of decreased revenue from the Industrial and Microfabrication markets, offset partially by increased revenue from the Aerospace and Defense market.
Cost of Revenues and Gross Margin
Cost of Laser Products revenue consists primarily of manufacturing materials, labor, shipping and handling costs, tariffs and manufacturing-related overhead. We order materials and supplies based on backlog and forecasted customer orders. We expense all warranty costs and inventory provisions as cost of revenues. Cost of Advanced Development revenue consists of materials, labor, subcontracting costs, and an allocation of indirect costs including overhead and general and administrative.
Our gross profit and gross margin were as follows (dollars in thousands):
| Year Ended December 31, 2025 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Laser Products | Advanced Development | Corporate and Other | Total | |||||||||||
| Gross profit | $ | 70,252 | $ | 10,181 | $ | (2,470) | $ | 77,963 | ||||||
| Gross margin | 39.2 | % | 12.4 | % | NM* | 29.8 | % |
| Year Ended December 31, 2024 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Laser Products | Advanced Development | Corporate and Other | Total | |||||||||||
| Gross profit | $ | 31,094 | $ | 4,363 | $ | (2,438) | $ | 33,019 | ||||||
| Gross margin | 22.8 | % | 7.0 | % | NM* | 16.6 | % |
28
Table of Contents
| Year Ended December 31, 2023 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Laser Products | Advanced Development | Corporate and Other | Total | |||||||||||
| Gross profit | $ | 44,891 | $ | 3,628 | $ | (2,406) | $ | 46,113 | ||||||
| Gross margin | 28.7 | % | 6.8 | % | NM* | 22.0 | % |
*NM - Not meaningful.
The increase in Laser Products gross margin for 2025 compared to 2024 was driven by primarily by changes in sales mix, which included increased sales of directed energy laser products, the impact of increased production volumes on fixed manufacturing costs due to the overall increase in sales as previously discussed, and an increase in duty reclaim and manufacturing yields. In addition, Laser Products gross margin in 2024 was negatively impacted by inventory charges related to products for the Industrial market in the fourth quarter of 2024. The increase in Advanced Development gross margin for 2025 compared to 2024 was primarily the result of an increase in revenue from fixed priced contracts that carried higher average gross margins than cost-plus fixed fee contracts.
The decrease in Laser Products gross margin for 2024 compared to 2023 was driven by the impact of lower sales and production volumes on fixed manufacturing costs due to the decrease in overall customer demand and inventory charges related to products for the Industrial market in the fourth quarter of 2024, offset partially by positive changes in sales mix. The increase in Advanced Development gross margin for 2024 compared to 2023 was not significant and was primarily the result of changes in the composition of development contracts.
Operating Expenses
Our operating expenses were as follows (dollars in thousands):
Research and Development
| Year Ended December 31, | Change | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 2024 | Amount | % | |||||||||||
| Research and development | $ | 47,972 | $ | 45,107 | $ | 2,865 | 6.4 | % |
| Year Ended December 31, | Change | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 2023 | Amount | % | |||||||||||
| Research and development | $ | 45,107 | $ | 46,163 | $ | (1,056) | (2.3) | % |
The increase in research and development expense for 2025 compared to 2024 was driven by an increase in stock-based compensation of $1.8 million, and increases in incentive compensation and indirect project-related spending that were partially offset by a decrease in outside services.
The decrease in research and development expense for 2024 compared to 2023 was driven by a decrease in stock-based compensation of $2.4 million, offset partially by increases in other employee compensation costs and project-related spending.
Sales, General and Administrative
| Year Ended December 31, | Change | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 2024 | Amount | % | |||||||||||
| Sales, general, and administrative | $ | 54,193 | $ | 49,257 | $ | 4,936 | 10.0 | % |
29
Table of Contents
| Year Ended December 31, | Change | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 2023 | Amount | % | |||||||||||
| Sales, general, and administrative | $ | 49,257 | $ | 45,899 | $ | 3,358 | 7.3 | % |
The increase in sales, general and administrative expense for 2025 compared to 2024 was primarily due to increases in stock-based compensation of $6.6 million and increases in employee and incentive compensation, partially offset by decreases in bad debt expense, increases in bad debt recoveries, and a higher allocation of costs from sales, general and administrative to development projects.
The increase in sales, general and administrative expense for 2024 compared to 2023 was primarily due to increases in bad debt expense of $2.3 million and stock-based compensation of $1.5 million. A higher allocation of costs from sales, general and administrative to development projects partially offset the overall increase in sales, general and administrative expense.
Restructuring
Restructuring included the following (in thousands):
| Year Ended December 31, | Change | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 2024 | $ | % | ||||||||||||
| Employee termination costs | $ | 1,141 | $ | 4,228 | $ | (3,087) | (73.0)% | ||||||||
| Write-off of long-lived assets | 1,207 | — | 1,207 | NM* | |||||||||||
| Other | — | 63 | (63) | (100.0) | |||||||||||
| $ | 2,348 | $ | 4,291 | $ | 4,291 | $ | (1,943) | (45.3)% |
| Year Ended December 31, | Change | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 2023 | $ | % | ||||||||||||
| Employee termination costs | $ | 4,228 | $ | 737 | $ | 3,491 | 473.7% | ||||||||
| Other | 63 | 79 | (16) | (20.0) | |||||||||||
| $ | 4,291 | $ | 817 | $ | 817 | $ | 3,474 | 425.2% |
During the third and fourth quarters of 2025, we implemented restructuring plans which included headcount reductions in China, Austria, Germany, and Finland, and the write-down of in-process capital equipment projects related to production capacity that had not been placed into service or redundant capital equipment we intend to sell. We implemented restructuring plans in the fourth quarters of 2024 and 2023 which resulted in reductions of headcount primarily in China, including the discontinuation of all manufacturing activities in China during the fourth quarter of 2024.
Interest Income
| Year Ended December 31, | Change | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 2024 | Amount | % | |||||||||||
| Interest income | $ | 4,906 | $ | 1,773 | $ | 3,133 | 176.7 | % |
30
Table of Contents
| Year Ended December 31, | Change | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 2023 | Amount | % | |||||||||||
| Interest income | $ | 1,773 | $ | 1,409 | $ | 364 | 25.8 | % |
The increase in interest income for 2025 compared to 2024, was driven primarily by an increase in income earned from marketable securities and imputed interest on a long-term customer receivable.
Interest income is primarily earned from our marketable securities (U.S. treasuries), recognized using the effective
yield method, and cash equivalents (money market securities).
Beginning with the three months ended March 31, 2025, income earned from marketable securities is classified
within interest income, net, rather than other income, net. This change in presentation more accurately reflects the nature of the income and has no impact on total net income.
The increase in interest income for 2024 compared to 2023 were driven by an increase in interest rates and the average cash and cash equivalents held in interest-bearing accounts.
Interest expense
| Year Ended December 31, | Change | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 2024 | Amount | % | |||||||||||
| Interest expense | $ | (1,084) | $ | (105) | $ | (979) | 932.4 | % |
| Year Ended December 31, | Change | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 2023 | Amount | % | |||||||||||
| Interest expense | $ | (105) | $ | (67) | $ | (38) | 56.7 | % |
The increases in interest expense for 2025 compared to 2024, and 2024 compared to 2023, were driven by interest on the outstanding line of credit.
Other Income (Expense), net
| Year Ended December 31, | Change | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 2024 | Amount | % | |||||||||||
| Other income (expense), net | $ | (40) | $ | 3,100 | $ | (3,140) | (101.3) | % |
| Year Ended December 31, | Change | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 2023 | Amount | % | |||||||||||
| Other income, net | $ | 3,100 | $ | 2,776 | $ | 324 | 11.7 | % |
The decrease in other income, net, in 2025 compared to 2024 was primarily attributable to changes in net realized and unrealized foreign exchange transactions resulting from currency rate fluctuations. The change in classification of income earned from marketable securities referenced above is the primary factor contributing to the year-over-year variance for other income, net from the same period in 2024. The increases in other income, net in 2024 compared to 2023 were driven by realized gains on sale of marketable securities.
Income Tax Expense (Benefit)
| Year Ended December 31, | Change | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 2024 | Amount | % | ||||||||||
| Income tax expense (benefit) | $ | 699 | $ | (76) | $ | 775 | NM* |
31
Table of Contents
| Year Ended December 31, | Change | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 2023 | Amount | % | |||||||||||
| Income tax expense (benefit) | $ | (76) | $ | (978) | $ | 902 | (92.2) | % |
We record income tax expense for taxes in our foreign jurisdictions including Finland, Italy, Austria, China and South Korea. While our tax expense is largely dependent on the geographic mix of earnings related to our foreign operations, we also record tax expense for uncertain tax positions taken and associated penalties and interest. We consider all available evidence, both positive and negative, in assessing the extent to which a valuation allowance should be applied against our deferred tax assets. Due to the uncertainty with respect to their ultimate realizability, we continue to maintain a full valuation allowance on deferred tax assets in the United States, and a partial valuation allowance in China as of December 31, 2025. Our effective tax rate may vary from period to period based on changes in estimated taxable income or loss by jurisdiction, changes to the valuation allowance, changes to U.S. federal, state or foreign tax laws, future expansion into areas with varying country, state, and local income tax rates and deductibility of certain costs and expenses by jurisdiction.
On July 4, 2025, the OBBBA was signed into law. Some of the tax related provisions of the OBBBA affecting corporations include but are not limited to expensing of domestic research expenses, increasing the limit of the deduction of interest expense deduction to thirty percent of EBITDA, and one hundred percent bonus depreciation on eligible property acquired after January 19, 2025. We evaluated the impact of the OBBBA on our financial condition and results of operations in future periods, and we do not anticipate a material change to our effective income tax rate or net deferred federal income tax assets as we maintain a full valuation allowance for all U.S. deferred tax assets.
Income tax expense in 2025 primarily relates to operations in China and Finland, partially offset by income tax reserve reversals. The increase in overall income tax expense for 2025 compared to 2024 was the result of a partial valuation allowance release in China during the fourth quarter of 2024, offset partially by income tax expense from other foreign tax jurisdictions.
The income tax benefit in 2024 was the result of a partial valuation allowance release in China during the fourth quarter of 2024, offset partially by income tax expense from other foreign tax jurisdictions. The decrease in overall income tax benefit for 2024 compared to 2023, was driven by a discrete tax benefit related to expiring statutes of limitations of unrecognized tax positions recorded in the second quarter of 2023.
Liquidity and Capital Resources
We had cash and cash equivalents and restricted cash of $99.0 million and $66.1 million as of December 31, 2025 and December 31, 2024, respectively. In addition, we had marketable securities of $34.9 million and $34.9 million at December 31, 2025 and December 31, 2024, respectively. Our total balance of cash, cash equivalents, restricted cash and marketable securities increased by $33.0 million from December 31, 2024 to December 31, 2025.
For the year ended December 31, 2025, our principal sources of liquidity included the draw of $20 million on our line of credit and cash collected from customers. We believe our existing sources of liquidity will be sufficient to meet our working capital and capital expenditure needs for at least the next 12 months. Our future capital requirements may vary materially from period to period and will depend on many factors, including the timing and extent of spending on research and development efforts, the expansion of sales and marketing activities, the continuing market acceptance of our products and ongoing investments to support the growth of our business. We may in the future enter into arrangements to acquire or invest in complementary businesses, services, technologies and intellectual property rights. From time to time, we may explore additional financing sources which could include equity, equity‑linked and debt financing arrangements.
32
Table of Contents
The following table summarizes our cash flows for the periods presented (in thousands):
| Year Ended December 31, | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 2024 | 2023 | ||||||||
| Net cash provided by (used in) operating activities | $ | 21,330 | $ | (2,359) | $ | 10,091 | ||||
| Net cash (used in) provided by investing activities | (8,771) | 16,690 | (14,100) | |||||||
| Net cash provided by (used in) financing activities | 20,110 | (1,303) | (859) | |||||||
| Effect of exchange rate changes on cash | 264 | (406) | 256 | |||||||
| Net increase (decrease) in cash and cash equivalents and restricted cash | $ | 32,933 | $ | 12,622 | $ | (4,612) |
Net Cash Provided By (Used In) Operating Activities
During the year ended December 31, 2025, net cash provided by operating activities was $21.3 million, which was the result of a $23.5 million net loss, offset by cash provided by working capital of $1.1 million and non‑cash expenses totaling $43.7 million related primarily to depreciation, amortization, and stock-based compensation. Changes in working capital were driven by a $14.7 million increase in accounts receivable,$4.1 million increase in inventory, offset by a $12 million increase in accounts payable and accrued expenses, $3.9 million increase in lease liabilities, and a $2.1 million decrease in deferred revenue.
During the year ended December 31, 2024, net cash used in operating activities was $2.4 million, which was the result of a $60.8 million net loss, offset by cash provided by working capital of $11.9 million and non‑cash expenses totaling $46.5 million related primarily to depreciation, amortization, and stock-based compensation. Changes in working capital were driven by an $11.0 million decrease in inventory and a $2.8 million decrease in accounts receivable.
Net Cash (Used In) Provided By Investing Activities
During the year ended December 31, 2025, net cash used in investing activities was $8.8 million, including the net purchase of $0.3 million of marketable securities and $8.5 million of capital expenditures related to investments in directed energy, manufacturing equipment and facilities.
During the year ended December 31, 2024, net cash provided by investing activities was $16.7 million, including the net sale of $24.6 million of marketable securities, partially offset by $7.9 million of capital expenditures related to investments in directed energy, manufacturing equipment and facilities.
Net Cash Provided By (Used In) Financing Activities
During the year ended December 31, 2025, net cash provided by financing activities was $20.1 million, which was primarily driven by $20 million of proceeds from our line of credit and $3.2 million of proceeds from stock options exercises and employee stock plan purchases, partially offset by $3.1 million of withholding tax payments related to the vesting of stock awards.
During the year ended December 31, 2024, net cash used in financing activities was $1.3 million, which was primarily driven by $4.5 million of withholding tax payments related to the vesting of stock awards, partially offset by $3.2 million of proceeds from stock options exercises and employee stock plan purchases.
Credit Facilities
We have a $40.0 million revolving line of credit "LOC" with Banc of California dated September 24, 2018, which is secured by our assets and matures on September 24, 2027. The LOC agreement contains restrictive and financial covenants and bears an unused credit fee of 0.25% on an annualized basis. The interest rate of 5.75% on the LOC at December 31, 2025 is based on the Prime Rate, minus a margin based on our liquidity levels.
During the year ended December 31, 2025, we drew $20.0 million under the LOC to support working capital and general corporate purposes. There was $20.0 million and $0.0 million outstanding under the LOC at December 31, 2025 and 2024, respectfully, and we were in compliance with all covenants. The remaining $20.0 million unused portion of the LOC is available for borrowing.
33
Table of Contents
Contractual Obligations
The following table sets forth a summary of our significant contractual obligations to make future payments in cash as of December 31, 2025 (in thousands):
| Payments Due by Year | ||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 2027 | 2028 | 2029 | 2030 | Thereafter | Total | ||||||||||||||||||||
| Purchase commitments | $ | 55,692 | $ | 55,692 | ||||||||||||||||||||||
| Lease obligations | 3,526 | 3,291 | 2,795 | 1,919 | 1,960 | 5,608 | 19,099 | |||||||||||||||||||
| Total | $ | 59,218 | $ | 3,291 | $ | 2,795 | $ | 1,919 | $ | 1,960 | $ | 5,608 | $ | 74,791 |
Critical Accounting Policies and Significant Estimates
Our discussion and analysis of our financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with generally accepted accounting principles in the United States of America (GAAP). The preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of net revenue and expenses in the reporting period. Our accounting policies are fundamental to understanding our financial condition and results of operations reported in our financial statements and related disclosures. We have identified the following accounting policies as being critical because they require our management to make particularly difficult, subjective and/or complex judgments about the effect of matters that are inherently uncertain.
Revenue Recognition
We recognize revenue upon transferring control of products and services and the amounts recognized reflect the consideration we expect to be entitled to receive in exchange for these products and services. We consider customer purchase orders, which in some cases are governed by master sales agreements, to be the contracts with a customer. As part of our consideration of the contract, we evaluate certain factors, including the customer's ability to pay (or credit risk). For each contract, we consider the promise to transfer products, each of which is distinct, as the identified performance obligations.
We allocate the transaction price to each distinct product based on its relative standalone selling price. Master sales agreements or purchase orders from customers could include a single product or multiple products. Regardless, the contracted price with the customer is agreed to at the individual product level outlined in the customer contract or purchase order. We do not bundle prices; however, we do negotiate with customers on pricing for the same products based on a variety of factors (e.g., level of contractual volume). We have concluded that the prices negotiated with each individual customer are representative of the stand-alone selling price of the product.
We often receive orders with multiple delivery dates that may extend across several reporting periods. We allocate the transaction price of the contract to each delivery based on the product standalone selling price and invoice for each scheduled delivery upon shipment or delivery and recognize revenues for such delivery at the point when transfer of control has occurred. As scheduled delivery dates are generally within one year, under the optional exemption provided by ASC 606-10-50-14a revenues allocated to future shipments of partially completed contracts are not disclosed as performance obligations for point in time revenue. Further, the Company recognizes over time revenue as per ASC 606-10-55-18 (invoice practical expedient) for its cost plus contracts and, accordingly, elects not to disclose information related to those performance obligations under ASC 606-10-50-14b.
We have elected, per ASC 606-10-25-18B (shipping and handling practical expedient), to recognize shipping and handling services performed after control transfer as fulfillment costs.
Rights of return generally are not included in customer contracts. Accordingly, product revenue is recognized upon transfer of control at shipment or delivery, as applicable. Rights of return are evaluated as they occur.
Revenues recognized at a point in time consist of sales of semiconductor lasers, fiber amplifiers, fiber lasers and other related products. Revenues recognized over time generally consist of development arrangements that are structured based on our costs incurred. For long-term contracts, we estimate the total expected costs to complete the contract and recognize revenue based on the percentage of costs incurred at period end. Typically, revenue is recognized over time using costs incurred to date relative to total estimated costs at completion to measure progress toward satisfying our performance obligations. Incurred costs represent work performed, which corresponds with, and thereby best depicts, the transfer of control to the customer. Contract costs include labor, materials, subcontractors costs, other direct costs, and indirect costs applicable on government and commercial contracts.
34
Table of Contents
Contract estimates are based on various assumptions to project the outcome of future events that may span several
years. These assumptions include labor productivity and availability, the complexity of the work to be performed, the
cost and availability of materials, the performance of subcontractors, and the availability and timing of funding from
the customer. Billing under these arrangements generally occurs within one month of the costs being incurred or as
milestones are reached.
Inventory Valuation
Inventory is stated at the lower of average cost (principally standard cost, which approximates actual cost on a first-in, first-out basis) and net realizable value. Inventory includes raw materials and components that may be specialized in nature and subject to obsolescence. On a quarterly basis, we review inventory quantities on hand in comparison to our past consumption, recent purchases, and other factors to determine what inventory quantities, if any, may not be sellable. Based on this analysis, we write down the affected inventory value for estimated excess and obsolescence charges. At the point of loss recognition, a new, lower-cost basis for that inventory is established, and subsequent changes in facts and circumstances do not result in the restoration or increase in that newly established cost basis.
Recent Accounting Pronouncements
See Note 1 of Notes to Consolidated Financial Statements.
MD&A history
Prior-year 10-K MD&A spans are extracted from SEC filings with the same bounded parser used for the latest filing. The latest 10-K appears above; prior years are below.
FY 2024 10-K MD&A
SEC filing source: 0001124796-25-000021.
ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
This Annual Report on Form 10-K contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In some cases, you can identify forward-looking statements by the following words: "ability," "anticipate," "attempt," "believe," "can be," "continue," "could," "depend," "enable," "estimate," "expect," "extend," "grow," "if," "intend," "likely," "may,"
23
Table of Contents
"objective," "ongoing," "plan," "possible," "potential," "predict," "project," "propose," "rely," "should," "target," "will," "would" or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words.
These statements involve risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from the information expressed or implied by these forward-looking statements. Although we believe that we have a reasonable basis for each forward-looking statement, we caution you that these statements are based on a combination of facts and factors currently known by us and our projections of the future, about which we cannot be certain. Forward-looking statements include, but are not limited to, statements about: our business model and strategic plans; our expectations regarding manufacturing; our future financial performance; demand for our semiconductor and fiber laser solutions; our ability to develop innovative products; our expectations regarding product volumes and the introduction of new products; our technology and new product research and development activities; the impact of new import and export controls; the impact of inflation; the impact of seasonality; the effect on our business of litigation to which we are or may become a party; and the sufficiency of our existing liquidity sources to meet our cash needs.
You should refer to the "Risk Factors" section of this report for a discussion of other important factors that may cause our actual results to differ materially from those expressed or implied by our forward-looking statements. As a result of these factors, we cannot assure you that the forward-looking statements in this report will prove to be accurate. In addition, statements that "we believe" and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based upon information available to us as of the date of this report, which although we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete, and our statements should not be read to indicate that we have conducted a thorough inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain and investors are cautioned not to unduly rely upon these statements. Furthermore, if our forward-looking statements prove to be inaccurate, the inaccuracy may be material. In light of the significant uncertainties in these forward-looking statements, you should not regard these statements as a representation or warranty by us or any other person that we will achieve our objectives and plans in any specified time frame, or at all. We undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
Overview
nLIGHT, Inc., headquartered in Camas, Washington, is a leading provider of high‑power semiconductor and fiber lasers for industrial, microfabrication, and aerospace and defense applications.
We operate in two reportable segments consisting of the Laser Products segment and the Advanced Development segment.
Revenues decreased to $198.5 million in the year ended December 31, 2024 compared to $209.9 million in 2023 due to a decrease in sales in the Laser Products segment that was partially offset by an increase in sales in the Advanced Development segment. We generated a net loss of $60.8 million for the year ended December 31, 2024 compared to a net loss of $41.7 million in 2023.
Factors Affecting Our Performance
Demand for our Products and Solutions
Our revenue depends largely on market conditions, competitive pressure, and achievement of design wins. We consider a design win to occur when a customer notifies us that it has selected one of our products to be incorporated into a product or system under development by such customer. In the Aerospace and Defense market, our business also depends in large part on continued investment in laser technology by the U.S. government and its allies, and our ability to continue to successfully develop leading technology in this area and commercialize that technology in the future.
Demand for our products also fluctuates based on market cycles, continuously evolving industry supply chains, trade and tariff terms, as well as evolving competitive dynamics in each of our end-markets. Erosion of average selling prices, or ASPs, of established products is typical in our industry, and the ASPs of our products generally decrease as our products mature. We may also negotiate discounted selling prices from time to time with certain customers that purchase higher volumes, or to penetrate new markets or applications.
24
Table of Contents
Technology and New Product Development
We invest heavily in the development of our semiconductor, fiber laser, directed energy, and laser-sensing technologies to provide solutions to our current and future customers. We anticipate that we will continue to invest in research and development to achieve our technology and product roadmap. Our product development is targeted to specific sectors of the market where we believe the performance of our products provides a significant benefit to our customers. We believe our close coordination with our customers regarding their future product requirements enhances the efficiency of our research and development expenditures.
Manufacturing Costs and Gross Margins
Product gross profit, in absolute dollars and gross margin, may fluctuate from period to period based on product sales mix, sales volumes, changes in ASPs, production volumes, the corresponding absorption of manufacturing overhead expenses, the cost of purchased materials, production costs and manufacturing yields. Product sales mix can affect gross profits due to variations in profitability related to product configurations and cost profiles, customer volume pricing, availability of competitive products in various markets, and new product introductions, among other factors. Even though certain of our products are built offshore by contract manufacturers, capacity utilization affects gross margin because of the fixed cost associated with our U.S.-based manufacturing capabilities. Change in sales and production volumes impact absorption of fixed costs, manufacturing efficiencies and production costs.
Our Development gross profit varies with the type and terms of contracts, contract volume, project mix, changes in the estimated cost of projects at completion, and successful execution on projects during the period. Most of our Development contracts have historically been structured as cost plus fixed fee due to the technical complexity of the research and development services, but we also perform work under fixed price contracts where gross margin can change from period to period based on the estimated cost of the project at completion.
Seasonality
Our quarterly revenues can fluctuate with general economic trends, the timing of capital expenditures by our customers, holidays, and general economic trends. In addition, as is typical in our industry, we tend to recognize a larger percentage of our quarterly revenues in the last month of the quarter, which may impact our working capital trends.
25
Table of Contents
Results of Operations
The following table sets forth our operating results as a percentage of revenues for the periods indicated (which may not add up due to rounding):
| Year Ended December 31, | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 2023 | 2022 | |||||||||
| Revenue: | |||||||||||
| Products | 68.8 | % | 74.6 | % | 79.6 | % | |||||
| Development | 31.2 | 25.4 | 20.4 | ||||||||
| Total revenue | 100.0 | 100.0 | 100.0 | ||||||||
| Cost of revenue: | |||||||||||
| Products | 54.4 | 54.4 | 60.0 | ||||||||
| Development | 29.0 | 23.6 | 19.0 | ||||||||
| Total cost of revenue | 83.4 | 78.0 | 79.0 | ||||||||
| Gross profit | 16.6 | 22.0 | 21.0 | ||||||||
| Operating expenses: | |||||||||||
| Research and development | 22.7 | 22.0 | 22.2 | ||||||||
| Sales, general and administrative | 24.8 | 21.8 | 19.9 | ||||||||
| Restructuring | 2.2 | 0.4 | 1.6 | ||||||||
| Total operating expenses | 49.7 | 44.2 | 43.8 | ||||||||
| Loss from operations | (33.1) | (22.2) | (22.8) | ||||||||
| Other income (expense): | |||||||||||
| Interest income, net | 0.9 | 0.5 | 0.2 | ||||||||
| Other income, net | 1.6 | 1.3 | 0.1 | ||||||||
| Loss before income taxes | (30.6) | (20.4) | (22.4) | ||||||||
| Income tax (benefit) expense | — | (0.5) | 0.1 | ||||||||
| Net loss | (30.6) | % | (19.9) | % | (22.5) | % |
Revenues by End Market
Our revenues by end market were as follows (dollars in thousands):
| Year Ended December 31, | Change | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | % of Revenue | 2023 | % of Revenue | Amount | % | |||||||||||||
| Industrial | $ | 45,615 | 23.0 | % | $ | 71,044 | 33.8 | % | $ | (25,429) | (35.8) | % | ||||||
| Microfabrication | 43,393 | 21.8 | 47,483 | 22.6 | (4,090) | (8.6) | ||||||||||||
| Aerospace and Defense | 109,540 | 55.2 | 91,394 | 43.6 | 18,146 | 19.9 | ||||||||||||
| $ | 198,548 | 100.0 | % | $ | 209,921 | 100.0 | % | $ | (11,373) | (5.4) | % |
| Year Ended December 31, | Change | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | % of Revenue | 2022 | % of Revenue | Amount | % | |||||||||||||
| Industrial | $ | 71,044 | 33.8 | % | $ | 91,098 | 37.6 | % | $ | (20,054) | (22.0) | % | ||||||
| Microfabrication | 47,483 | 22.6 | 62,769 | 25.9 | (15,286) | (24.4) | ||||||||||||
| Aerospace and Defense | 91,394 | 43.6 | 88,191 | 36.4 | 3,203 | 3.6 | ||||||||||||
| $ | 209,921 | 100.0 | % | $ | 242,058 | 100.0 | % | $ | (32,137) | (13.3) | % |
The decrease in Industrial market revenue for 2024 compared to 2023 was primarily the result of decreased unit sales across all regions due to deteriorating market conditions and lower customer demand in cutting and additive
26
Table of Contents
manufacturing. The decrease in Microfabrication market revenue for 2024 compared to 2023 was primarily attributable to decreased unit sales of semiconductor lasers in EMEA(1) and Asia Pacific, offset partially by increased unit sales in North America. The increase in Aerospace and Defense market revenue for 2024 compared to 2023 was the result of increased unit sales of products due to higher demand, an increase in ASPs, and increased development revenue from development contracts awarded primarily in the second half of 2023.
The decreases in Industrial and Microfabrication market revenue for 2023 compared to 2022 were the result of decreased unit sales across all regions due primarily to lower customer demand and deteriorating market conditions. The increase in Aerospace and Defense market revenue in 2023 compared to 2022 was driven by new development contracts, offset partially by a decrease in product sales.
Revenues by Segment
Our revenues by segment were as follows (dollars in thousands):
| Year Ended December 31, | Change | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | % of Revenue | 2023 | % of Revenue | Amount | % | |||||||||||||
| Laser Products | $ | 136,659 | 68.8 | % | $ | 156,666 | 74.6 | % | $ | (20,007) | (12.8) | % | ||||||
| Advanced Development | 61,889 | 31.2 | 53,255 | 25.4 | 8,634 | 16.2 | ||||||||||||
| $ | 198,548 | 100.0 | % | $ | 209,921 | 100.0 | % | $ | (11,373) | (5.4) | % |
| Year Ended December 31, | Change | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | % of Revenue | 2022 | % of Revenue | Amount | % | |||||||||||||
| Laser Products | $ | 156,666 | 74.6 | % | $ | 192,658 | 79.6 | % | $ | (35,992) | (18.7) | % | ||||||
| Advanced Development | 53,255 | 25.4 | 49,400 | 20.4 | 3,855 | 7.8 | ||||||||||||
| $ | 209,921 | 100.0 | % | $ | 242,058 | 100.0 | % | $ | (32,137) | (13.3) | % |
The decrease in Laser Products revenue for 2024 compared to 2023 was driven by decreased sales to both the Industrial and Microfabrication markets as discussed above, offset partially by increased sales to the Aerospace and Defense market. The increase in Advanced Development revenue for 2024 compared to 2023 was the result of increased activity on development contracts awarded primarily in the second half of 2023. All Advanced Development revenue is included in the Aerospace and Defense market.
The decrease in Laser Products revenue for 2023 compared to 2022 was primarily due to decreased units sales to the Industrial and Microfabrication markets as discussed above. The increase in Advanced Development revenue was driven by new development contracts. Most of our Advanced Development revenue in 2023 was generated from cost plus fixed fee development contracts, and all Advanced Development revenue is included in the Aerospace and Defense market.
Revenues by Geographic Region
Our revenues by geographic region were as follows (dollars in thousands):
| Year Ended December 31, | Change | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | % of Revenue | 2023 | % of Revenue | Amount | % | |||||||||||||
| North America | $ | 132,812 | 66.9 | % | $ | 129,311 | 61.6 | % | $ | 3,501 | 2.7 | % | ||||||
| Asia Pacific | 38,137 | 19.2 | 45,765 | 21.8 | (7,628) | (16.7) | ||||||||||||
| EMEA(1) | 27,599 | 13.9 | 34,845 | 16.6 | (7,246) | (20.8) | ||||||||||||
| $ | 198,548 | 100.0 | % | $ | 209,921 | 100.0 | % | $ | (11,373) | (5.4) | % |
(1) EMEA consists of Europe, the Middle East, and Africa.
27
Table of Contents
| Year Ended December 31, | Change | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | % of Revenue | 2022 | % of Revenue | Amount | % | |||||||||||||
| North America | $ | 129,311 | 61.6 | % | $ | 137,454 | 56.8 | % | $ | (8,143) | (5.9) | % | ||||||
| Asia Pacific | 45,765 | 21.8 | 67,315 | 27.8 | (21,550) | (32.0) | ||||||||||||
| EMEA | 34,845 | 16.6 | 37,289 | 15.4 | (2,444) | (6.6) | ||||||||||||
| $ | 209,921 | 100.0 | % | $ | 242,058 | 100.0 | % | $ | (32,137) | (13.3) | % |
Geographic revenue information is based on the location to which we deliver our products and services.
The increase in North America revenue for 2024 compared to 2023 was the result of increased revenue from the Aerospace and Defense market and Microfabrication market, partially offset by decreased revenue from the Industrial market. The decrease in Asia Pacific revenue for 2024 compared to 2023 was the result of decreased revenue from all end markets. The decrease in EMEA revenue for 2024 compared to 2023 was the result of decreased revenue from the Industrial and Microfabrication markets, offset partially by increased revenue from the Aerospace and Defense market.
The decrease in North America revenue for 2023 compared to 2022 was the result of decreased revenue from the Industrial and Microfabrication markets, partially offset by an increase in revenue from the Aerospace and Defense market. The decrease in Asia Pacific and EMEA revenue for 2023 compared to 2022 was driven by decreases in revenue from the Industrial and Microfabrication markets as discussed above.
Cost of Revenues and Gross Margin
Cost of Laser Products revenue consists primarily of manufacturing materials, labor, shipping and handling costs, tariffs and manufacturing-related overhead. We order materials and supplies based on backlog and forecasted customer orders. We expense all warranty costs and inventory provisions as cost of revenues. Cost of Advanced Development revenue consists of materials, labor, subcontracting costs, and an allocation of indirect costs including overhead and general and administrative.
Our gross profit and gross margin were as follows (dollars in thousands):
| Year Ended December 31, 2024 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Laser Products | Advanced Development | Corporate and Other | Total | |||||||||||
| Gross profit | $ | 31,094 | $ | 4,363 | $ | (2,438) | $ | 33,019 | ||||||
| Gross margin | 22.8 | % | 7.0 | % | NM* | 16.6 | % |
| Year Ended December 31, 2023 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Laser Products | Advanced Development | Corporate and Other | Total | |||||||||||
| Gross profit | $ | 44,891 | $ | 3,628 | $ | (2,406) | $ | 46,113 | ||||||
| Gross margin | 28.7 | % | 6.8 | % | NM* | 22.0 | % |
| Year Ended December 31, 2022 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Laser Products | Advanced Development | Corporate and Other | Total | |||||||||||
| Gross profit | $ | 50,063 | $ | 3,435 | $ | (2,677) | $ | 50,821 | ||||||
| Gross margin | 26.0 | % | 7.0 | % | NM* | 21.0 | % |
*NM - Not meaningful.
28
Table of Contents
The decrease in Laser Products gross margin for 2024 compared to 2023 was driven by the impact of lower sales and production volumes on fixed manufacturing costs due to the decrease in overall customer demand and inventory charges related to products for the Industrial market in the fourth quarter of 2024, offset partially by positive changes in sales mix. The increase in Advanced Development gross margin for 2024 compared to 2023 was not significant and was primarily the result of changes in the composition of research and development contracts.
The increase in Laser Products gross margin for 2023 compared to 2022 was driven by a decrease in direct labor and other variable manufacturing costs, and a decrease in manufacturing variances, partially offset by the impact of lower production volumes on fixed manufacturing costs due to the decrease in customer demand. Manufacturing variances in 2022 included inventory charges related to business restructuring and the discontinuation of certain product lines in the fourth quarter of 2022. The decrease in Advanced Development gross margin for 2023 compared to 2022 was not significant and was primarily the result of changes in the composition of research and development contracts.
Operating Expenses
Our operating expenses were as follows (dollars in thousands):
Research and Development
| Year Ended December 31, | Change | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 2023 | Amount | % | ||||||||||
| Research and development | $ | 45,107 | $ | 46,163 | $ | (1,056) | (2.3) |
| Year Ended December 31, | Change | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | 2022 | Amount | % | ||||||||||
| Research and development | $ | 46,163 | $ | 53,773 | $ | (7,610) | (14.2) |
The decrease in research and development expense for 2024 compared to 2023 was driven by a decrease in stock-based compensation of $2.4 million, offset partially by increases in other employee compensation costs and project-related spending.
The decrease in research and development expense for 2023 compared to 2022 was due primarily to decreases in salary costs and project-related expenses, an increase in costs allocated from research and development to development projects, and a decrease in stock-based compensation of $1.8 million.
Sales, General and Administrative
| Year Ended December 31, | Change | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 2023 | Amount | % | ||||||||||
| Sales, general, and administrative | $ | 49,257 | $ | 45,899 | $ | 3,358 | 7.3 |
| Year Ended December 31, | Change | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | 2022 | Amount | % | ||||||||||
| Sales, general, and administrative | $ | 45,899 | $ | 48,258 | $ | (2,359) | (4.9) |
The increase in sales, general and administrative expense for 2024 compared to 2023 was primarily due to increases in bad debt expense of $2.3 million and stock-based compensation of $1.5 million. A higher allocation of costs from sales, general and administrative to development projects partially offset the overall increase in sales, general and administrative expense.
The decrease in sales, general and administrative expense for 2023 compared to 2022 was primarily due to a decrease in salary costs and incentive compensation, and an increase in administrative costs allocated from sales, general and administrative to development projects, partially offset by an increase in stock-based compensation of $1.2 million.
29
Table of Contents
Restructuring
Restructuring included the following (in thousands):
| Year Ended December 31, | Change | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 2023 | Amount | % | |||||||||||
| Employee termination costs | $ | 4,228 | $ | 737 | $ | 3,491 | 473.7 | |||||||
| Other | 63 | 79 | (16) | (20) | % | |||||||||
| $ | 4,291 | $ | 817 | $ | 3,474 | 425.2 | % |
| Year Ended December 31, | Change | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | 2022 | Amount | % | |||||||||||
| Employee termination costs | $ | 737 | $ | 1,271 | $ | (534) | (42.0) | % | ||||||
| Write-off of long-lived assets | — | 2,566 | (2,566) | (100.0) | ||||||||||
| Other | 79 | 55 | 24 | 43.6 | ||||||||||
| $ | 817 | $ | 3,892 | $ | (3,075) | (79.0) | % |
We implemented restructuring plans in the fourth quarters of 2024 and 2023 which resulted in reductions of headcount primarily in China, including the discontinuation of all manufacturing in China during the fourth quarter of 2024. During the fourth quarter of 2022, we implemented a restructuring plan which included headcount reductions in both the U.S. and China, and the write-down of certain in-process capital equipment projects related to production capacity that were never completed or placed into service.
Interest Income, net
Interest income, net was as follows (in thousands):
| Year Ended December 31, | Change | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 2023 | Amount | % | ||||||||||
| Interest income, net | $ | 1,668 | $ | 1,342 | $ | 326 | 24.3 |
| Year Ended December 31, | Change | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | 2022 | Amount | % | ||||||||||
| Interest income, net | $ | 1,342 | $ | 529 | $ | 813 | 153.7 |
The increases in interest income, net for 2024 compared to 2023 and 2023 compared to 2022 were driven by increases in interest rates and the average cash and cash equivalents held in interest-bearing accounts.
Other Income, net
| Year Ended December 31, | Change | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 2023 | Amount | % | ||||||||||
| Other income, net | $ | 3,100 | $ | 2,776 | $ | 324 | 11.7 |
30
Table of Contents
| Year Ended December 31, | Change | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | 2022 | Amount | % | ||||||||||
| Other income, net | $ | 2,776 | $ | 338 | $ | 2,438 | 721.3 |
The increases in other income, net, in 2024 compared to 2023 and in 2023 compared to 2022 were driven by realized gains on the sale of marketable securities.
Income Tax Expense (Benefit)
| Year Ended December 31, | Change | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 2023 | Amount | % | ||||||||||
| Income tax benefit | $ | (76) | $ | (978) | $ | 902 | 92.2 |
| Year Ended December 31, | Change | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | 2022 | Amount | % | ||||||||||
| Income tax expense (benefit) | $ | (978) | $ | 344 | $ | (1,322) | (384.3) |
We record income tax expense for taxes in our foreign jurisdictions including Finland, Italy, Austria, and South Korea. While our tax expense is largely dependent on the geographic mix of earnings related to our foreign operations, we also record tax expense for uncertain tax positions taken and associated penalties and interest. We consider all available evidence, both positive and negative, in assessing the extent to which a valuation allowance should be applied against our deferred tax assets. Due to the uncertainty with respect to their ultimate realizability, we continue to maintain a full valuation allowance on deferred tax assets in the United States, and a partial valuation allowance in China as of December 31, 2024. Our effective tax rate may vary from period to period based on changes in estimated taxable income or loss by jurisdiction, changes to the valuation allowance, changes to U.S. federal, state or foreign tax laws, future expansion into areas with varying country, state, and local income tax rates and deductibility of certain costs and expenses by jurisdiction.
The income tax benefit in 2024 was the result of a partial valuation allowance release in China during the fourth quarter of 2024, offset partially by income tax expense from other foreign tax jurisdictions. The decrease in overall income tax benefit for 2024 compared to 2023, and decrease in expense for 2023 compared to 2022, was driven by a discrete tax benefit related to expiring statutes of limitations of unrecognized tax positions recorded in the second quarter of 2023.
Liquidity and Capital Resources
Total cash and cash equivalents, restricted cash and marketable securities were $101.0 million and $113.2 million as of December 31, 2024 and 2023, respectively. We had cash and cash equivalents and restricted cash of $66.1 million and $53.5 million as of December 31, 2024 and 2023, respectively, and marketable securities of $34.9 million and $59.7 million as of December 31, 2024 and 2023, respectively.
For the year ended December 31, 2024, our principal uses of liquidity were to fund operating activities, acquire plant and equipment and make tax payments related to stock award issuances. The primary sources of cash were collections from customers and net proceeds from the sale of marketable securities.
We believe our existing sources of liquidity, including sales to customers and our line of credit, will be sufficient to meet our working capital and capital expenditure needs for at least the next 12 months. Our future capital requirements may vary materially from period to period and will depend on many factors, including the timing and extent of spending on research and development efforts, the expansion of sales and marketing activities, the continuing market acceptance of our products and ongoing investments to support the growth of our business. We may in the future enter into arrangements to acquire or invest in complementary businesses, services, technologies and intellectual property rights. From time to time, we may explore additional financing sources which could include equity, equity‑linked and debt financing arrangements.
31
Table of Contents
The following table summarizes our cash flows for the periods presented (in thousands):
| Year Ended December 31, | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 2023 | 2022 | ||||||||
| Net cash (used in) provided by operating activities | $ | (2,359) | $ | 10,091 | $ | (14,542) | ||||
| Net cash provided by (used in) investing activities | 16,690 | (14,100) | (72,381) | |||||||
| Net cash used in financing activities | (1,303) | (859) | (1,306) | |||||||
| Effect of exchange rate changes on cash | (406) | 256 | (477) | |||||||
| Net increase (decrease) in cash and cash equivalents and restricted cash | $ | 12,622 | $ | (4,612) | $ | (88,706) |
Net Cash (Used in) Provided by Operating Activities
During the year ended December 31, 2024, net cash used in operating activities was $2.4 million, which was the result of a $60.8 million net loss, offset by cash provided by working capital of $11.9 million and non‑cash expenses totaling $46.5 million related primarily to depreciation, amortization, and stock-based compensation. Changes in working capital were driven by an $11.0 million decrease in inventory and a $2.8 million decrease in accounts receivable.
During the year ended December 31, 2023, net cash provided by operating activities was $10.1 million, which was the result of a $41.7 million net loss, offset by cash provided by working capital of $8.1 million and non‑cash expenses totaling $43.7 million related primarily to depreciation, amortization, and stock-based compensation. Changes in working capital were driven by a $14.9 million decrease in inventory, partially offset by a $4.5 million decrease in accounts payable.
Net Cash Provided by (Used in) Investing Activities
During the year ended December 31, 2024, net cash provided by investing activities was $16.7 million, including the net sale of $24.6 million of marketable securities, partially offset by $7.9 million of capital expenditures related to investments in directed energy, manufacturing equipment and facilities.
During the year ended December 31, 2023, net cash used in investing activities was $14.1 million, including the net purchase of $8.8 million of marketable securities and $5.3 million of capital expenditures related to investments in directed energy, manufacturing equipment and facilities.
Net Cash Used in Financing Activities
During the year ended December 31, 2024, net cash used in financing activities was $1.3 million, which was primarily driven by $4.5 million of withholding tax payments related to the vesting of stock awards, partially offset by $3.2 million of proceeds from stock options exercises and employee stock plan purchases.
During the year ended December 31, 2023, net cash used in financing activities was $0.9 million, which was primarily driven by $4.0 million of withholding tax payments related to the vesting of stock awards, partially offset by $3.1 million of proceeds from stock options exercises and employee stock plan purchases.
Credit Facilities
We have a $40.0 million revolving line of credit, or LOC, with Banc of California dated September 24, 2018, which is secured by our assets.
On September 24, 2024, we amended the LOC to extend the maturity date to September 24, 2027, updated financial covenants, and amended the unused line fee and interest rate applicable to revolving loans.
The LOC agreement contains restrictive and financial covenants and bears an unused credit fee of 0.25% on an annualized basis. The interest rate on the LOC is based on the Prime Rate, minus a margin based on our liquidity levels. No amounts were outstanding under the LOC at December 31, 2024 or 2023 and we were in compliance with all covenants.
32
Table of Contents
Contractual Obligations
The following table sets forth a summary of our significant contractual obligations to make future payments in cash as of December 31, 2024 (in thousands):
| Payments Due by Year | ||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 2026 | 2027 | 2028 | 2029 | Thereafter | Total | ||||||||||||||||||||
| Purchase commitments | $ | 64,628 | $ | — | $ | — | $ | — | $ | — | $ | — | $ | 64,628 | ||||||||||||
| Lease obligations | 2,786 | 2,087 | 2,005 | 1,699 | 1,028 | 4,417 | 14,022 | |||||||||||||||||||
| Total | $ | 67,414 | $ | 2,087 | $ | 2,005 | $ | 1,699 | $ | 1,028 | $ | 4,417 | $ | 78,650 |
Critical Accounting Policies and Significant Estimates
Our discussion and analysis of our financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with generally accepted accounting principles in the United States of America (GAAP). The preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of net revenue and expenses in the reporting period. Our accounting policies are fundamental to understanding our financial condition and results of operations reported in our financial statements and related disclosures. We have identified the following accounting policies as being critical because they require our management to make particularly difficult, subjective and/or complex judgments about the effect of matters that are inherently uncertain.
Revenue Recognition
We recognize revenue upon transferring control of products and services and the amounts recognized reflect the consideration we expect to be entitled to receive in exchange for these products and services. We consider customer purchase orders, which in some cases are governed by master sales agreements, to be the contracts with a customer. As part of our consideration of the contract, we evaluate certain factors, including the customer's ability to pay (or credit risk). For each contract, we consider the promise to transfer products, each of which is distinct, as the identified performance obligations.
We allocate the transaction price to each distinct product based on its relative standalone selling price. Master sales agreements or purchase orders from customers could include a single product or multiple products. Regardless, the contracted price with the customer is agreed to at the individual product level outlined in the customer contract or purchase order. We do not bundle prices; however, we do negotiate with customers on pricing for the same products based on a variety of factors (e.g., level of contractual volume). We have concluded that the prices negotiated with each individual customer are representative of the stand-alone selling price of the product.
We often receive orders with multiple delivery dates that may extend across several reporting periods. We allocate the transaction price of the contract to each delivery based on the product standalone selling price and invoice for each scheduled delivery upon shipment or delivery and recognize revenues for such delivery at the point when transfer of control has occurred. As scheduled delivery dates are generally within one year, under the optional exemption provided by ASC 606-10-50-14a revenues allocated to future shipments of partially completed contracts are not disclosed as performance obligations for point in time revenue. Further, the Company recognizes over time revenue as per ASC 606-10-55-18 (invoice practical expedient) for its cost plus contracts and, accordingly, elects not to disclose information related to those performance obligations under ASC 606-10-50-14b.
Rights of return generally are not included in customer contracts. Accordingly, product revenue is recognized upon transfer of control at shipment or delivery, as applicable. Rights of return are evaluated as they occur.
Revenues recognized at a point in time consist of sales of semiconductor lasers, fiber lasers, and certain defense and other products. Revenues recognized over time generally consist of development arrangements that are structured based on our costs incurred. Because control transfers over time, revenue is recognized based on the extent of progress towards completion of the performance obligation. We generally use the cost-to-cost measure of progress for our contracts because it best depicts the transfer of control to the customer. Billing under these arrangements generally occurs within one month after the work is completed.
Inventory Valuation
Inventory is stated at the lower of average cost (principally standard cost, which approximates actual cost on a first-in, first-out basis) and net realizable value. Inventory includes raw materials and components that may be specialized in nature and subject to obsolescence. On a quarterly basis, we review inventory quantities on hand in comparison to our past consumption, recent purchases, and other factors to determine what inventory quantities, if
33
Table of Contents
any, may not be sellable. Based on this analysis, we write down the affected inventory value for estimated excess and obsolescence charges. At the point of loss recognition, a new, lower-cost basis for that inventory is established, and subsequent changes in facts and circumstances do not result in the restoration or increase in that newly established cost basis.
Inflation
We do not believe that inflation had a material effect on our business, financial condition or results of operations during the year ended December 31, 2024. If our costs become subject to significant inflationary pressures, we may not be able to fully offset such higher costs through price increases. Our inability or failure to do so could materially adversely affect our business, financial condition and results of operations.
Recent Accounting Pronouncements
See Note 1 of Notes to Consolidated Financial Statements.
FY 2023 10-K MD&A
SEC filing source: 0001124796-24-000018.
ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
This Annual Report on Form 10-K contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In some cases, you can identify forward-looking statements by the following words: "ability," "anticipate," "attempt," "believe," "can be," "continue," "could," "depend," "enable," "estimate," "expect," "extend," "grow," "if," "intend," "likely," "may,"
22
Table of Contents
"objective," "ongoing," "plan," "possible," "potential," "predict," "project," "propose," "rely," "should," "target," "will," "would" or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words.
These statements involve risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from the information expressed or implied by these forward-looking statements. Although we believe that we have a reasonable basis for each forward-looking statement, we caution you that these statements are based on a combination of facts and factors currently known by us and our projections of the future, about which we cannot be certain. Forward-looking statements include, but are not limited to, statements about: our business model and strategic plans; our expectations regarding manufacturing; our future financial performance; demand for our semiconductor and fiber laser solutions; our ability to develop innovative products; our expectations regarding product volumes and the introduction of new products; our technology and new product research and development activities; the impact of the implementation of our new ERP system; the impact of new import and export controls; the impact of inflation; the impact of seasonality; the effect on our business of litigation to which we are or may become a party; and the sufficiency of our existing liquidity sources to meet our cash needs.
You should refer to the "Risk Factors" section of this report for a discussion of other important factors that may cause our actual results to differ materially from those expressed or implied by our forward-looking statements. As a result of these factors, we cannot assure you that the forward-looking statements in this report will prove to be accurate. In addition, statements that "we believe" and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based upon information available to us as of the date of this report, which although we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete, and our statements should not be read to indicate that we have conducted a thorough inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain and investors are cautioned not to unduly rely upon these statements. Furthermore, if our forward-looking statements prove to be inaccurate, the inaccuracy may be material. In light of the significant uncertainties in these forward-looking statements, you should not regard these statements as a representation or warranty by us or any other person that we will achieve our objectives and plans in any specified time frame, or at all. We undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
Overview
nLIGHT, Inc., headquartered in Camas, Washington, is a leading provider of high‑power semiconductor and fiber lasers for industrial, microfabrication, and aerospace and defense applications. We operate in two reportable segments consisting of the Laser Products segment and the Advanced Development segment. Sales of our semiconductor lasers, fiber lasers, fiber amplifiers, and directed energy products are included in the Laser Products segment, while revenue earned from research and development contracts are included in the Advanced Development segment.
Revenues decreased to $209.9 million in the year ended December 31, 2023 compared to $242.1 million in 2022 due to a decrease in sales in the Laser Products segment that was partially offset by an increase in sales in the Advanced Development segment. We generated a net loss of $41.7 million for the year ended December 31, 2023 compared to a net loss of $54.6 million in 2022.
Factors Affecting Our Performance
Demand for our Semiconductor and Fiber Laser Solutions
Our revenue growth depends on market demand and achievement of design wins for our semiconductor and fiber lasers. We consider a design win to occur when a customer notifies us that it has selected one of our products to be incorporated into a product or system under development by such customer. For the foreseeable future, our operations will continue to depend upon capital expenditures by customers in the Industrial and Microfabrication markets, which, in turn, depend upon the demand for these customers’ products or services. In addition, in the Aerospace and Defense market, our business depends in large part on continued investment in laser technology by the U.S. government and its allies, and our ability to continue to successfully develop leading technology in this area and commercialize that technology in the future.
Demand for our products also fluctuates based on market cycles, continuously evolving industry supply chains, trade and tariff terms, as well as evolving competitive dynamics in each of our end-markets. Erosion of average
23
Table of Contents
selling prices, or ASPs, of established products is typical in our industry, and the ASPs of our products generally decrease as our products mature. We may also negotiate discounted selling prices from time to time with certain customers that purchase higher volumes, or to penetrate new markets or applications. Historically, we have been able to offset decreasing ASPs by introducing new and higher value products, increasing the sales of our existing products, expanding into new applications and reducing our product and manufacturing costs. Although we anticipate further increases in product volumes and the continued introduction of new and higher value products, ASP reduction may cause our revenues to decline or grow at a slower rate.
Technology and New Product Development
We invest heavily in the development of our semiconductor, fiber laser, directed energy, and laser-sensing technologies to provide solutions to our current and future customers. We anticipate that we will continue to invest in research and development to achieve our technology and product roadmap. Our product development is targeted to specific sectors of the market where we believe the performance of our products provide a significant benefit to our customers. We believe our close coordination with our customers regarding their future product requirements enhances the efficiency of our research and development expenditures.
Manufacturing Costs and Gross Margins
Our product gross profit, in absolute dollars and as a percentage of revenues, is impacted by our product sales mix, sales volumes, changes in ASPs, production volumes, the corresponding absorption of manufacturing overhead expenses, the cost of purchased materials, production costs and manufacturing yields. Our product sales mix can affect gross profits due to variations in profitability related to product configurations and cost profiles, customer volume pricing, availability of competitive products in various markets, and new product introductions, among other factors. We have invested heavily in U.S.-based manufacturing capabilities in the last several years. Capacity utilization affects our gross margin because we have a high fixed cost base due to our vertically integrated business model. Increases in sales and production volumes drive favorable absorption of fixed costs, improved manufacturing efficiencies and lower production costs. Gross margins may fluctuate from period to period depending on product mix and the level of capacity utilization.
Our Development gross profit varies with the type and terms of contracts, contract volume, project mix, changes in the estimated cost of projects at completion, and successful execution on projects during the period. Most of our Development contracts have historically been structured as cost plus fixed fee due to the technical complexity of the research and development services, but we also perform work under fixed price contracts where gross margin can change from period to period based on the estimated cost of the project at completion.
Seasonality
Our quarterly revenues can fluctuate with general economic trends, the timing of capital expenditures by our customers, holidays, and general economic trends. In addition, as is typical in our industry, we tend to recognize a larger percentage of our quarterly revenues in the last month of the quarter, which may impact our working capital trends.
24
Table of Contents
Results of Operations
The following table sets forth our operating results as a percentage of revenues for the periods indicated (which may not add up due to rounding):
| Year Ended December 31, | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | 2022 | 2021 | |||||||||
| Revenue: | |||||||||||
| Products | 74.6 | % | 79.6 | % | 76.3 | % | |||||
| Development | 25.4 | 20.4 | 23.7 | ||||||||
| Total revenue | 100.0 | 100.0 | 100.0 | ||||||||
| Cost of revenue: | |||||||||||
| Products | 54.4 | 60.0 | 49.2 | ||||||||
| Development | 23.6 | 19.0 | 22.2 | ||||||||
| Total cost of revenue | 78.0 | 79.0 | 71.4 | ||||||||
| Gross profit | 22.0 | 21.0 | 28.6 | ||||||||
| Operating expenses: | |||||||||||
| Research and development | 22.0 | 22.2 | 20.3 | ||||||||
| Sales, general and administrative | 21.8 | 19.9 | 19.5 | ||||||||
| Restructuring | 0.4 | 1.6 | — | ||||||||
| Total operating expenses | 44.2 | 43.8 | 39.8 | ||||||||
| Loss from operations | (22.2) | (22.8) | (11.2) | ||||||||
| Other income (expense): | |||||||||||
| Interest income (expense), net | 0.5 | 0.2 | (0.1) | ||||||||
| Other income, net | 1.3 | 0.1 | 0.1 | ||||||||
| Loss before income taxes | (20.4) | (22.4) | (11.2) | ||||||||
| Income tax expense (benefit) | (0.5) | 0.1 | (0.1) | ||||||||
| Net loss | (19.9) | % | (22.5) | % | (11.1) | % |
Revenues by End Market
Our revenues by end market were as follows (dollars in thousands):
| Year Ended December 31, | Change | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | % of Revenue | 2022 | % of Revenue | Amount | % | |||||||||||||
| Industrial | $ | 71,044 | 33.8 | % | $ | 91,098 | 37.6 | % | $ | (20,054) | (22.0) | % | ||||||
| Microfabrication | 47,483 | 22.6 | 62,769 | 25.9 | (15,286) | (24.4) | ||||||||||||
| Aerospace and Defense | 91,394 | 43.6 | 88,191 | 36.4 | 3,203 | 3.6 | ||||||||||||
| $ | 209,921 | 100.0 | % | $ | 242,058 | 100.0 | % | $ | (32,137) | (13.3) | % |
| Year Ended December 31, | Change | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022 | % of Revenue | 2021 | % of Revenue | Amount | % | |||||||||||||
| Industrial | $ | 91,098 | 37.6 | % | $ | 94,795 | 35.1 | % | $ | (3,697) | (3.9) | % | ||||||
| Microfabrication | 62,769 | 25.9 | 70,412 | 26.1 | (7,643) | (10.9) | ||||||||||||
| Aerospace and Defense | 88,191 | 36.4 | 104,939 | 38.8 | (16,748) | (16.0) | ||||||||||||
| $ | 242,058 | 100.0 | % | $ | 270,146 | 100.0 | % | $ | (28,088) | (10.4) | % |
The decrease in Industrial and Microfabrication market revenue for 2023 compared to 2022 was the result of decreased unit sales across all regions due primarily to lower customer demand and deteriorating market
25
Table of Contents
conditions. The increase in Aerospace and Defense market revenue in 2023 compared to 2022 was driven by new development contracts, offset partially by a decrease in product sales.
The decrease in Industrial and Microfabrication market revenue for 2022 compared to 2021 was driven by a decrease in unit sales in China, partially offset by an increase in unit sales outside of China. The closure of our Shanghai facility for approximately two months during the second quarter of 2022 due to the COVID-19 pandemic had a negative impact on unit sales in China. The decrease in revenue from the Aerospace and Defense market for 2022 compared to 2021 was due to decreased activity on development contracts, and a decrease in product sales in the second half of 2022 due primarily to supply chain disruptions.
Revenues by Segment
Our revenues by segment were as follows (dollars in thousands):
| Year Ended December 31, | Change | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | % of Revenue | 2022 | % of Revenue | Amount | % | |||||||||||||
| Laser Products | $ | 156,666 | 74.6 | % | $ | 192,658 | 79.6 | % | $ | (35,992) | (18.7) | % | ||||||
| Advanced Development | 53,255 | 25.4 | 49,400 | 20.4 | 3,855 | 7.8 | ||||||||||||
| $ | 209,921 | 100.0 | % | $ | 242,058 | 100.0 | % | $ | (32,137) | (13.3) | % |
| Year Ended December 31, | Change | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022 | % of Revenue | 2021 | % of Revenue | Amount | % | |||||||||||||
| Laser Products | $ | 192,658 | 79.6 | % | $ | 206,195 | 76.3 | % | $ | (13,537) | (6.6) | % | ||||||
| Advanced Development | 49,400 | 20.4 | 63,951 | 23.7 | (14,551) | (22.8) | ||||||||||||
| $ | 242,058 | 100.0 | % | $ | 270,146 | 100.0 | % | $ | (28,088) | (10.4) | % |
The decrease in Laser Products revenue for 2023 compared to 2022 was primarily due to decreased units sales to the Industrial and Microfabrication markets as discussed above. The increase in Advanced Development revenue was driven by new development contracts. Most of our Advanced Development revenue in 2023 was generated from cost plus fixed fee development contracts, and all Advanced Development revenue is included in the Aerospace and Defense market.
The decrease in Laser Products revenue for 2022 compared to 2021 was driven by decreased units sales across each end market as discussed above. The decrease in Advanced Development revenue for 2022 compared to 2021 was primarily due to decreased activity on development contracts.
Revenues by Geographic Region
Our revenues by geographic region were as follows (dollars in thousands):
| Year Ended December 31, | Change | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | % of Revenue | 2022 | % of Revenue | Amount | % | |||||||||||||
| North America | $ | 129,311 | 61.6 | % | $ | 137,454 | 56.8 | % | $ | (8,143) | (5.9) | % | ||||||
| China | 11,890 | 5.7 | 21,287 | 8.8 | (9,397) | (44.1) | ||||||||||||
| Rest of World | 68,720 | 32.7 | 83,317 | 34.4 | (14,597) | (17.5) | ||||||||||||
| $ | 209,921 | 100.0 | % | $ | 242,058 | 100.0 | % | $ | (32,137) | (13.3) | % |
26
Table of Contents
| Year Ended December 31, | Change | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022 | % of Revenue | 2021 | % of Revenue | Amount | % | |||||||||||||
| North America | $ | 137,454 | 56.8 | % | $ | 143,232 | 53.0 | % | $ | (5,778) | (4.0) | % | ||||||
| China | 21,287 | 8.8 | 55,446 | 20.5 | (34,159) | (61.6) | ||||||||||||
| Rest of World | 83,317 | 34.4 | 71,468 | 26.5 | 11,849 | 16.6 | ||||||||||||
| $ | 242,058 | 100.0 | % | $ | 270,146 | 100.0 | % | $ | (28,088) | (10.4) | % |
Geographic revenue information is based on the location to which we deliver our products and services.
The decrease in North America revenue for 2023 compared to 2022 was the result of decreased revenue from the Industrial and Microfabrication markets, partially offset by an increase in revenue from the Aerospace and Defense market. The decrease in China and Rest of World revenue for 2023 compared to 2022 was driven by decreases in revenue from the Industrial and Microfabrication markets as discussed above.
The decrease in North America revenue for 2022 compared to 2021 was primarily due to decreased revenue from the Aerospace and Defense market, partially offset by increased revenue from the Industrial market. The decrease in China revenue for 2022 compared to 2021 was the result of decreased sales in the Industrial and Microfabrication markets, primarily as a result of deteriorating market conditions. The closure of our Shanghai facility for approximately two months during the second quarter of 2022 due to the COVID-19 pandemic also had a negative impact on 2022 sales in China. The increase in Rest of World revenue for 2022 compared to 2021 was due to increased revenue from the Microfabrication and Industrial markets.
Cost of Revenues and Gross Margin
Cost of Laser Products revenue consists primarily of manufacturing materials, labor, shipping and handling costs, tariffs and manufacturing-related overhead. We order materials and supplies based on backlog and forecasted customer orders. We expense all warranty costs and inventory provisions as cost of revenues. Cost of Advanced Development revenue consists of materials, labor, subcontracting costs, an allocation of indirect costs including overhead and general and administrative.
Our gross profit and gross margin were as follows (dollars in thousands):
| Year Ended December 31, 2023 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Laser Products | Advanced Development | Corporate and Other | Total | |||||||||||
| Gross profit | $ | 44,891 | $ | 3,628 | $ | (2,406) | $ | 46,113 | ||||||
| Gross margin | 28.7 | % | 6.8 | % | NM* | 22.0 | % |
| Year Ended December 31, 2022 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Laser Products | Advanced Development | Corporate and Other | Total | |||||||||||
| Gross profit | $ | 50,063 | $ | 3,435 | $ | (2,677) | $ | 50,821 | ||||||
| Gross margin | 26.0 | % | 7.0 | % | NM* | 21.0 | % |
| Year Ended December 31, 2021 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Laser Products | Advanced Development | Corporate and Other | Total | |||||||||||
| Gross profit | $ | 75,833 | $ | 3,979 | $ | (2,505) | $ | 77,307 | ||||||
| Gross margin | 36.8 | % | 6.2 | % | NM* | 28.6 | % |
*NM - Not meaningful.
27
Table of Contents
The increase in Laser Products gross margin for 2023 compared to 2022 was driven by a decrease in direct labor and other variable manufacturing costs, and a decrease in manufacturing variances, partially offset by the impact of lower production volumes on fixed manufacturing costs due to the decrease in customer demand. Manufacturing variances in 2022 included inventory charges related to business restructuring and the discontinuation of certain product lines in the fourth quarter of 2022. The decrease in Advanced Development gross margin for 2023 compared to 2022 was not significant and was primarily the result of changes in the composition of research and development contracts.
The decrease in Laser Products gross margin for 2022 compared to 2021 was driven by sales mix, decreased factory utilization, increased labor and material costs, and increased freight costs, partially offset by an increase in duty reclaim. In addition, Laser Products gross margin in 2022 was negatively impacted by inventory charges related to business restructuring and the discontinuation of certain product lines in the fourth quarter of 2022. The increase in Advanced Development gross margin for 2022 compared to 2021 was not significant and was primarily the result of changes in the mix of research and development contracts.
Operating Expenses
Our operating expenses were as follows (dollars in thousands):
Research and Development
| Year Ended December 31, | Change | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | 2022 | Amount | % | ||||||||||
| Research and development | $ | 46,163 | $ | 53,773 | $ | (7,610) | (14.2) |
| Year Ended December 31, | Change | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022 | 2021 | Amount | % | ||||||||||
| Research and development | $ | 53,773 | $ | 54,814 | $ | (1,041) | (1.9) |
The decrease in research and development expense for 2023 compared to 2022 was due primarily to decreases in salary costs and project-related expenses, an increase in costs allocated from research and development to development projects, and a decrease in stock-based compensation of $1.8 million.
The decrease in research and development expense for 2022 compared to 2021 was driven by a decrease in stock-based compensation of $1.8 million and a decrease in purchased intangible amortization of $1.2 million, partially offset by increases in salary costs and project-related expenses.
Sales, General and Administrative
| Year Ended December 31, | Change | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | 2022 | Amount | % | ||||||||||
| Sales, general, and administrative | $ | 45,899 | $ | 48,258 | $ | (2,359) | (4.9) |
| Year Ended December 31, | Change | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022 | 2021 | Amount | % | ||||||||||
| Sales, general, and administrative | $ | 48,258 | $ | 52,710 | $ | (4,452) | (8.4) |
The decrease in sales, general and administrative expense for 2023 compared to 2022 was primarily due to a decrease in salary costs and incentive compensation, and an increase in administrative costs allocated from sales, general and administrative to development projects, partially offset by an increase in stock-based compensation of $1.2 million.
The decrease in sales, general and administrative expense for 2022 compared to 2021 was primarily due to a decrease in stock-based compensation of $9.4 million, partially offset by increases in salary costs, professional service fees and facility expenses, and a decrease in administrative costs allocated from sales, general and
28
Table of Contents
administrative to development projects. The decrease in stock-based compensation was the result of forfeitures and decreases in expected achievement related to performance-based stock awards.
Restructuring
Restructuring included the following (in thousands):
| Year Ended December 31, | Change | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | 2022 | Amount | % | |||||||||||
| Employee termination costs | $ | 737 | $ | 1,271 | $ | (534) | (42.0) | % | ||||||
| Write-off of long-lived assets | — | 2,566 | (2,566) | (100.0) | ||||||||||
| Other | 79 | 55 | 24 | 43.6 | ||||||||||
| $ | 817 | $ | 3,892 | $ | (3,075) | (79.0) | % |
We implemented a restructuring plan in the fourth quarter of 2023 which resulted in a reduction of headcount in China. During the fourth quarter of 2022, we implemented a restructuring plan which included headcount reductions in both the U.S. and China, and the write-down of certain in-process capital equipment projects related to production capacity that were never completed or placed into service.
Interest Income (Expense), net
Interest income (expense), net was as follows (in thousands):
| Year Ended December 31, | Change | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | 2022 | Amount | % | ||||||||||
| Interest income, net | $ | 1,342 | $ | 529 | $ | 813 | 153.7 |
| Year Ended December 31, | Change | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022 | 2021 | Amount | % | ||||||||||
| Interest income (expense), net | $ | 529 | $ | (163) | $ | 692 | 424.5 |
The increase in net interest income for 2023 compared to 2022 was driven by an increase in marketable securities and interest rates. The increase in net interest income for 2022 compared to 2021 was driven by increases in interest rates and the investment in marketable securities during the second quarter of 2022, as well as the payoff of our long-term debt in the third quarter of 2021.
Other Income, net
| Year Ended December 31, | Change | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | 2022 | Amount | % | ||||||||||
| Other income, net | $ | 2,776 | $ | 338 | $ | 2,438 | 721.3 |
| Year Ended December 31, | Change | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022 | 2021 | Amount | % | ||||||||||
| Other income, net | $ | 338 | $ | 336 | $ | 2 | 0.6 |
The increase in other income, net, in 2023 compared to 2022, was driven by realized gains on the sale of marketable securities. The change in other income, net, in 2022 compared to 2021 was not significant and consisted primarily of net realized and unrealized foreign exchange transactions resulting from currency rate fluctuations.
29
Table of Contents
Income Tax Expense (Benefit)
| Year Ended December 31, | Change | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | 2022 | Amount | % | ||||||||||
| Income tax expense (benefit) | $ | (978) | $ | 344 | $ | (1,322) | (384.3) |
| Year Ended December 31, | Change | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022 | 2021 | Amount | % | ||||||||||
| Income tax expense (benefit) | $ | 344 | $ | (375) | $ | 719 | 191.7 |
We record income tax expense for taxes in our foreign jurisdictions including Finland, Italy, Austria, and South Korea. While our tax expense is largely dependent on the geographic mix of earnings related to our foreign operations, we also record tax expense for uncertain tax positions taken and associated penalties and interest. We consider all available evidence, both positive and negative, in assessing the extent to which a valuation allowance should be applied against our deferred tax assets. Due to the uncertainty with respect to their ultimate realizability in the United States and China, we continue to maintain a full valuation allowance in these jurisdictions as of December 31, 2023. Our effective tax rate may vary from period to period based on changes in estimated taxable income or loss by jurisdiction, changes to the valuation allowance, changes to U.S. federal, state or foreign tax laws, future expansion into areas with varying country, state, and local income tax rates and deductibility of certain costs and expenses by jurisdiction.
The income tax benefit for 2023 compared to the income tax expense for 2022 was driven by a discrete tax benefit related to expiring statutes of limitations of unrecognized tax positions recorded in the second quarter of 2023. The increase in income tax expense for 2022 compared to 2021 was driven by a discrete tax benefit related to return to provision true ups and expiring statutes of limitations of unrecognized tax positions recorded in the second quarter of 2021.
Liquidity and Capital Resources
Total cash, cash equivalents and marketable securities were $113.1 million and $108.5 million as of December 31, 2023 and 2022, respectively. We had cash and cash equivalents of $53.5 million and $58.1 million as of December 31, 2023 and 2022, respectively, and marketable securities of $59.7 million and $50.4 million as of December 31, 2023 and 2022, respectively.
For the year ended December 31, 2023, our principal uses of liquidity were to fund operating activities, acquire plant and equipment and tax payments related to stock award issuances. The primary source of cash was collections from customers.
We believe our existing sources of liquidity will be sufficient to meet our working capital and capital expenditure needs for at least the next 12 months. Our future capital requirements may vary materially from period to period and will depend on many factors, including the timing and extent of spending on research and development efforts, the expansion of sales and marketing activities, the continuing market acceptance of our products and ongoing investments to support the growth of our business. We may in the future enter into arrangements to acquire or invest in complementary businesses, services, technologies and intellectual property rights. From time to time, we may explore additional financing sources which could include equity, equity‑linked and debt financing arrangements.
The following table summarizes our cash flows for the periods presented (in thousands):
| Year Ended December 31, | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | 2022 | 2021 | ||||||||
| Net cash provided by (used in) operating activities | $ | 10,091 | $ | (14,542) | $ | (7,443) | ||||
| Net cash used in investing activities | (14,100) | (72,381) | (21,853) | |||||||
| Net cash (used in) provided by financing activities | (859) | (1,306) | 73,742 | |||||||
| Effect of exchange rate changes on cash | 256 | (477) | (235) | |||||||
| Net (decrease) increase in cash, cash equivalents, and restricted cash | $ | (4,612) | $ | (88,706) | $ | 44,211 |
30
Table of Contents
Net Cash Provided by (Used in) Operating Activities
During the year ended December 31, 2023, net cash provided by operating activities was $10.1 million, which was the result of a $41.7 million net loss, offset by cash provided by working capital of $8.1 million and non‑cash expenses totaling $43.7 million related primarily to depreciation, amortization, and stock-based compensation. Changes in working capital were driven by a $14.9 million decrease in inventory, partially offset by a $4.5 million decrease in accounts payable.
During the year ended December 31, 2022, net cash used in operating activities was $14.5 million, which was the result of a $54.6 million net loss and use of cash for working capital of $8.2 million, offset partially by non‑cash expenses totaling $48.3 million related primarily to depreciation, amortization, and stock-based compensation. Changes in working capital were driven by a $5.9 million decrease in accounts payable and a $4.6 million decrease in inventory due to a decrease in inventory purchasing.
Net Cash Used in Investing Activities
During the year ended December 31, 2023, net cash used in investing activities was $14.1 million, including the net purchase of $8.8 million of marketable securities and $5.3 million of capital expenditures related to investments in directed energy, manufacturing equipment and facilities.
During the year ended December 31, 2022, net cash used in investing activities was $72.4 million, including the net purchase of $50.0 million of marketable securities and $21.4 million of capital expenditures related to investments in directed energy, manufacturing equipment and facilities.
Net Cash (Used in) Provided by Financing Activities
During the year ended December 31, 2023, net cash used in financing activities was $0.9 million, which was primarily driven by $4.0 million of withholding tax payments related to the vesting of stock awards, partially offset by $3.1 million of proceeds from stock options exercises and employee stock plan purchases.
During the year ended December 31, 2022, net cash used in financing activities was $1.3 million, which was primarily driven by $4.9 million of withholding tax payments related to the vesting of stock awards, partially offset by $3.6 million of proceeds from stock options exercises and employee stock plan purchases.
Credit Facilities
We have a $40.0 million revolving line of credit, or LOC, with Pacific Western Bank dated September 24, 2018, which is secured by our assets and expires September 24, 2024.
The LOC agreement contains restrictive and financial covenants and bears an unused credit fee of 0.20% on an annualized basis. The interest rate on the LOC is based on the Prime rate, minus a margin of 0.50% to 1.40% based on our liquidity levels. No amounts were outstanding under the LOC at December 31, 2023 and 2022 and we were in compliance with all covenants.
Contractual Obligations
The following table sets forth a summary of our significant contractual obligations to make future payments in cash as of December 31, 2023 (in thousands):
| Payments Due by Year | ||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 2025 | 2026 | 2027 | 2028 | Thereafter | Total | ||||||||||||||||||||
| Purchase commitments | $ | 33,979 | $ | — | $ | — | $ | — | $ | — | $ | — | $ | 33,979 | ||||||||||||
| Lease obligations | 3,687 | 2,408 | 1,741 | 1,688 | 1,413 | 5,410 | 16,347 | |||||||||||||||||||
| Total | $ | 37,666 | $ | 2,408 | $ | 1,741 | $ | 1,688 | $ | 1,413 | $ | 5,410 | $ | 50,326 |
Critical Accounting Policies and Significant Estimates
Our discussion and analysis of our financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with generally accepted accounting principles in the
31
Table of Contents
United States of America (GAAP). The preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of net revenue and expenses in the reporting period. Our accounting policies are fundamental to understanding our financial condition and results of operations reported in our financial statements and related disclosures. We have identified the following accounting policies as being critical because they require our management to make particularly difficult, subjective and/or complex judgments about the effect of matters that are inherently uncertain.
Revenue Recognition
We recognize revenue upon transferring control of products and services and the amounts recognized reflect the consideration we expect to be entitled to receive in exchange for these products and services. We consider customer purchase orders, which in some cases are governed by master sales agreements, to be the contracts with a customer. As part of our consideration of the contract, we evaluate certain factors, including the customer's ability to pay (or credit risk). For each contract, we consider the promise to transfer products, each of which is distinct, as the identified performance obligations.
We allocate the transaction price to each distinct product based on its relative standalone selling price. Master sales agreements or purchase orders from customers could include a single product or multiple products. Regardless, the contracted price with the customer is agreed to at the individual product level outlined in the customer contract or purchase order. We do not bundle prices; however, we do negotiate with customers on pricing for the same products based on a variety of factors (e.g., level of contractual volume). We have concluded that the prices negotiated with each individual customer are representative of the stand-alone selling price of the product.
We often receive orders with multiple delivery dates that may extend across several reporting periods. We allocate the transaction price of the contract to each delivery based on the product standalone selling price and invoice for each scheduled delivery upon shipment or delivery and recognize revenues for such delivery at the point when transfer of control has occurred. As scheduled delivery dates are generally within one year, under the optional exemption provided by ASC 606-10-50-14a revenues allocated to future shipments of partially completed contracts are not disclosed as performance obligations for point in time revenue. Further, the Company recognizes over time revenue as per ASC 606-10-55-18 (invoice practical expedient) for its cost plus contracts and, accordingly, elects not to disclose information related to those performance obligations under ASC 606-10-50-14b.
Rights of return generally are not included in customer contracts. Accordingly, product revenue is recognized upon transfer of control at shipment or delivery, as applicable. Rights of return are evaluated as they occur.
Revenues recognized at a point in time consist of sales of semiconductor lasers, fiber lasers, and certain defense and other products. Revenues recognized over time generally consist of development arrangements that are structured based on our costs incurred. Because control transfers over time, revenue is recognized based on the extent of progress towards completion of the performance obligation. We generally use the cost-to-cost measure of progress for our contracts because it best depicts the transfer of control to the customer. Billing under these arrangements generally occurs within one month after the work is completed.
Inventory Valuation
Inventory is stated at the lower of average cost (principally standard cost, which approximates actual cost on a first-in, first-out basis) and net realizable value. Inventory includes raw materials and components that may be specialized in nature and subject to obsolescence. On a quarterly basis, we review inventory quantities on hand in comparison to our past consumption, recent purchases, and other factors to determine what inventory quantities, if any, may not be sellable. Based on this analysis, we write down the affected inventory value for estimated excess and obsolescence charges. At the point of loss recognition, a new, lower-cost basis for that inventory is established, and subsequent changes in facts and circumstances do not result in the restoration or increase in that newly established cost basis.
Inflation
We do not believe that inflation had a material effect on our business, financial condition or results of operations during the year ended December 31, 2023. If our costs become subject to significant inflationary pressures, we may not be able to fully offset such higher costs through price increases. Our inability or failure to do so could materially adversely affect our business, financial condition and results of operations.
32
Table of Contents
Recent Accounting Pronouncements
See Note 1 of Notes to Consolidated Financial Statements.
FY 2022 10-K MD&A
SEC filing source: 0001124796-23-000018.
ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
This Annual Report on Form 10-K contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In some
21
Table of Contents
cases, you can identify forward-looking statements by the following words: "ability," "anticipate," "attempt," "believe," "can be," "continue," "could," "depend," "enable," "estimate," "expect," "extend," "grow," "if," "intend," "likely," "may," "objective," "ongoing," "plan," "possible," "potential," "predict," "project," "propose," "rely," "should," "target," "will," "would" or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words.
These statements involve risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from the information expressed or implied by these forward-looking statements. Although we believe that we have a reasonable basis for each forward-looking statement, we caution you that these statements are based on a combination of facts and factors currently known by us and our projections of the future, about which we cannot be certain. Forward-looking statements include, but are not limited to, statements about: our business model and strategic plans; our expectations regarding manufacturing; the impact of the COVID-19 pandemic and the related lockdown in Shanghai on our business; our future financial performance; demand for our semiconductor and fiber laser solutions; our ability to develop innovative products; our expectations regarding product volumes and the introduction of new products; our technology and new product research and development activities; the impact of the implementation of our new ERP system; the impact of new import and export controls; the impact of inflation; the impact of seasonality; the effect on our business of litigation to which we are or may become a party; and the sufficiency of our existing liquidity sources to meet our cash needs.
You should refer to the "Risk Factors" section of this report for a discussion of other important factors that may cause our actual results to differ materially from those expressed or implied by our forward-looking statements. As a result of these factors, we cannot assure you that the forward-looking statements in this report will prove to be accurate. In addition, statements that "we believe" and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based upon information available to us as of the date of this report, which although we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete, and our statements should not be read to indicate that we have conducted a thorough inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain and investors are cautioned not to unduly rely upon these statements. Furthermore, if our forward-looking statements prove to be inaccurate, the inaccuracy may be material. In light of the significant uncertainties in these forward-looking statements, you should not regard these statements as a representation or warranty by us or any other person that we will achieve our objectives and plans in any specified time frame, or at all. We undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
Overview
nLIGHT, Inc., is a leading provider of high‑power semiconductor and fiber lasers for industrial, microfabrication, and aerospace and defense applications. Headquartered in Camas, Washington, we design, develop, and manufacture the critical elements of our lasers, and believe our vertically integrated business model enables us to rapidly introduce innovative products, control our costs and protect our intellectual property.
We operate in two reportable segments consisting of the Laser Products segment and the Advanced Development segment. Sales of our semiconductor lasers, fiber lasers and directed energy products are included in the Laser Products segment, while revenue earned from research and development contracts are included in the Advanced Development segment.
Revenues decreased to $242.1 million in the year ended December 31, 2022 compared to $270.1 million in the same period of 2021 due primarily to decreases in product sales to customers in China and development revenue, partially offset by an increase in product sales to customers outside of China. We generated a net loss of $54.6 million for the year ended December 31, 2022 compared to a net loss of $29.7 million for the same period of 2021.
Factors Affecting Our Performance
Demand for our Semiconductor and Fiber Laser Solutions
In order to continue to grow our revenues, we must continue to achieve design wins for our semiconductor and fiber lasers. We consider a design win to occur when a customer notifies us that it has selected one of our products to be incorporated into a product or system under development by such customer. For the foreseeable future, our operations will continue to depend upon capital expenditures by customers in the Industrial and Microfabrication markets, which, in turn, depend upon the demand for these customers’ products or services. In addition, in the
22
Table of Contents
Aerospace and Defense market, our business depends in large part on continued investment in laser technology by the U.S. government and its allies, and our ability to continue to successfully develop leading technology in this area and commercialize that technology in the future.
Demand for our products also fluctuates based on market cycles, continuously evolving industry supply chains, trade and tariff terms, as well as evolving competitive dynamics in each of our end-markets. Erosion of average selling prices, or ASPs, of established products is typical in our industry, and the ASPs of our products generally decrease as our products mature. We may also negotiate discounted selling prices from time to time with certain customers that purchase higher volumes, or to penetrate new markets or applications. Historically, we have been able to offset decreasing ASPs by introducing new and higher value products, increasing the sales of our existing products, expanding into new applications and reducing our product and manufacturing costs. Although we anticipate further increases in product volumes and the continued introduction of new and higher value products, ASP reduction may cause our revenues to decline or grow at a slower rate.
Technology and New Product Development
We invest heavily in the development of our semiconductor, fiber laser and directed energy technologies to provide solutions to our current and future customers. We anticipate that we will continue to invest in research and development to achieve our technology and product roadmap. Our product development is targeted to specific sectors of the market where we believe the performance of our products provide a significant benefit to our customers. We believe our close coordination with our customers regarding their future product requirements enhances the efficiency of our research and development expenditures.
Manufacturing Costs and Gross Margins
Our product gross profit, in absolute dollars and as a percentage of revenues, is impacted by our product sales mix, sales volumes, changes in ASPs, production volumes, the corresponding absorption of manufacturing overhead expenses, production costs and manufacturing yields. Our product sales mix can affect gross profits due to variations in profitability related to product configurations and cost profiles, customer volume pricing, availability of competitive products in various markets, and new product introductions, among other factors. We have invested heavily in U.S.-based manufacturing capabilities in the last several years. Capacity utilization affects our gross margin because we have a high fixed cost base due to our vertically integrated business model. Increases in sales and production volumes drive favorable absorption of fixed costs, improved manufacturing efficiencies and lower production costs. Gross margins may fluctuate from period to period depending on product mix and the level of capacity utilization.
Our Development gross profit varies with the type and terms of contracts, contract volume, project mix, and successful execution on projects during the period. Most of our Development contracts are structured as cost plus fixed fee due to the technical complexity of the research and development services.
COVID-19 Pandemic
The COVID-19 pandemic and related global liquidity concerns and macro-economic volatility adversely impacted our end-markets, including reduced economic activity and demand for our products, and delays in new capital expenditure decisions and implementations. While our manufacturing operations generally remained open throughout the pandemic, including our manufacturing facilities in the United States, the COVID-related lockdown of Shanghai by the Chinese government forced us to halt operations in our Shanghai manufacturing facility for approximately two months during the second quarter of 2022. Our Shanghai facility manufactures products that are sold directly to end customers as well as components that are shipped to our facilities in the United States to be integrated into finished products. Although we are increasing our manufacturing capabilities outside of China, our Shanghai manufacturing facility remains an important part of our global operations. The closure of our Shanghai facility during the second quarter of 2022 had a negative impact on our 2022 annual financial results, and any additional closures, or partial closures, could have an adverse impact on future periods.
Seasonality
Our quarterly revenues can fluctuate with general economic trends, the timing of capital expenditures by our customers, holidays, and general economic trends. In addition, as is typical in our industry, we tend to recognize a
23
Table of Contents
larger percentage of our quarterly revenues in the last month of the quarter, which may impact our working capital trends.
Results of Operations
The following table sets forth our operating results as a percentage of revenues for the periods indicated (which may not add up due to rounding):
| Year Ended December 31, | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022 | 2021 | 2020 | |||||||||
| Revenue: | |||||||||||
| Products | 79.6 | % | 76.3 | % | 83.0 | % | |||||
| Development | 20.4 | 23.7 | 17.0 | ||||||||
| Total revenue | 100.0 | 100.0 | 100.0 | ||||||||
| Cost of revenue: | |||||||||||
| Products | 60.0 | 49.2 | 57.6 | ||||||||
| Development | 19.0 | 22.2 | 15.8 | ||||||||
| Total cost of revenue | 79.0 | 71.4 | 73.4 | ||||||||
| Gross profit | 21.0 | 28.6 | 26.6 | ||||||||
| Operating expenses: | |||||||||||
| Research and development | 22.2 | 20.3 | 18.5 | ||||||||
| Sales, general and administrative | 19.9 | 19.5 | 17.6 | ||||||||
| Restructuring | 1.6 | — | — | ||||||||
| Total operating expenses | 43.8 | 39.8 | 36.1 | ||||||||
| Loss from operations | (22.8) | (11.2) | (9.4) | ||||||||
| Other income (expense): | |||||||||||
| Interest income (expense), net | 0.2 | (0.1) | — | ||||||||
| Other income, net | 0.1 | 0.1 | 0.2 | ||||||||
| Loss before income taxes | (22.4) | (11.2) | (9.2) | ||||||||
| Income tax expense (benefit) | 0.1 | (0.1) | 0.2 | ||||||||
| Net loss | (22.5) | % | (11.1) | % | (9.4) | % |
Revenues by End Market
Our revenues by end market were as follows (dollars in thousands):
| Year Ended December 31, | Change | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022 | % of Revenue | 2021 | % of Revenue | Amount | % | |||||||||||||
| Industrial | $ | 91,098 | 37.6 | % | $ | 94,795 | 35.1 | % | $ | (3,697) | (3.9) | % | ||||||
| Microfabrication | 62,769 | 25.9 | 70,412 | 26.1 | (7,643) | (10.9) | ||||||||||||
| Aerospace and Defense | 88,191 | 36.4 | 104,939 | 38.8 | (16,748) | (16.0) | ||||||||||||
| $ | 242,058 | 100.0 | % | $ | 270,146 | 100.0 | % | $ | (28,088) | (10.4) | % |
| Year Ended December 31, | Change | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | % of Revenue | 2020 | % of Revenue | Amount | % | |||||||||||||
| Industrial | $ | 94,795 | 35.1 | % | $ | 84,478 | 37.9 | % | $ | 10,317 | 12.2 | % | ||||||
| Microfabrication | 70,412 | 26.1 | 51,649 | 23.2 | 18,763 | 36.3 | ||||||||||||
| Aerospace and Defense | 104,939 | 38.8 | 86,662 | 38.9 | 18,277 | 21.1 | ||||||||||||
| $ | 270,146 | 100.0 | % | $ | 222,789 | 100.0 | % | $ | 47,357 | 21.3 | % |
24
Table of Contents
The decrease in Industrial and Microfabrication market revenue for 2022 compared to 2021 was driven by a decrease in unit sales in China, partially offset by an increase in unit sales outside of China. The closure of our Shanghai facility for approximately two months during the second quarter of 2022 due to the COVID-19 pandemic had a negative impact on unit sales in China. The decrease in revenue from the Aerospace and Defense market for 2022 compared to 2021 was due to decreased activity on research and development contracts, and a decrease in product sales in the second half of 2022 due primarily to supply chain disruptions.
The increase in Industrial market revenue for 2021 compared to 2020 was driven by increases in unit sales outside of China, partially offset by a decrease in unit sales in China and lower average selling prices due to changes in product mix. The increase in unit sales outside of China was driven by increased customer demand for fiber lasers used in cutting applications and new products for additive manufacturing, while the decrease in unit sales in China was the result of increased competitive pressure and declining sales prices for fiber lasers used in cutting applications. The increase in Microfabrication market revenue for 2021 compared to 2020 was attributable to increases in customer demand and unit sales of semiconductor lasers. The increase in Aerospace and Defense market revenue for 2021 compared to 2020 was primarily due to increased activity on existing research and development contracts, offset partially by a decrease in product sales.
Revenues by Segment
Our revenues by segment were as follows (dollars in thousands):
| Year Ended December 31, | Change | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022 | % of Revenue | 2021 | % of Revenue | Amount | % | |||||||||||||
| Laser Products | $ | 192,658 | 79.6 | % | $ | 206,195 | 76.3 | % | $ | (13,537) | (6.6) | % | ||||||
| Advanced Development | 49,400 | 20.4 | 63,951 | 23.7 | (14,551) | (22.8) | ||||||||||||
| $ | 242,058 | 100.0 | % | $ | 270,146 | 100.0 | % | $ | (28,088) | (10.4) | % |
| Year Ended December 31, | Change | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | % of Revenue | 2020 | % of Revenue | Amount | % | |||||||||||||
| Laser Products | $ | 206,195 | 76.3 | % | $ | 184,841 | 83.0 | % | $ | 21,354 | 11.6 | % | ||||||
| Advanced Development | 63,951 | 23.7 | 37,948 | 17.0 | 26,003 | 68.5 | ||||||||||||
| $ | 270,146 | 100.0 | % | $ | 222,789 | 100.0 | % | $ | 47,357 | 21.3 | % |
The decrease in Laser Products revenue for 2022 compared to 2021 was driven by decreased units sales across each end market as discussed above. The decrease in Advanced Development revenue for 2022 compared to 2021 was primarily due to decreased activity on research and development contracts. Most of our Advanced Development revenue is generated from cost plus fixed fee research and development contracts, and all Advanced Development revenue is included in the Aerospace and Defense market.
The increase in Laser Products revenue for 2021 compared to 2020 was primarily due to higher revenue and demand from the Industrial and Microfabrication markets outside of China, offset partially by a decrease in product sales to the Aerospace and Defense market. The increase in Advanced Development revenue for 2021 compared to 2020 was driven by increased activity on existing research and development contracts with the U.S. Government.
Revenues by Geographic Region
Our revenues by geographic region were as follows (dollars in thousands):
| Year Ended December 31, | Change | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022 | % of Revenue | 2021 | % of Revenue | Amount | % | |||||||||||||
| North America | $ | 137,454 | 56.8 | % | $ | 143,232 | 53.0 | % | $ | (5,778) | (4.0) | % | ||||||
| China | 21,287 | 8.8 | 55,446 | 20.5 | (34,159) | (61.6) | ||||||||||||
| Rest of World | 83,317 | 34.4 | 71,468 | 26.5 | 11,849 | 16.6 | ||||||||||||
| $ | 242,058 | 100.0 | % | $ | 270,146 | 100.0 | % | $ | (28,088) | (10.4) | % |
25
Table of Contents
| Year Ended December 31, | Change | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | % of Revenue | 2020 | % of Revenue | Amount | % | |||||||||||||
| North America | $ | 143,232 | 53.0 | % | $ | 107,624 | 48.3 | % | $ | 35,608 | 33.1 | % | ||||||
| China | 55,446 | 20.5 | 70,882 | 31.8 | (15,436) | (21.8) | ||||||||||||
| Rest of World | 71,468 | 26.5 | 44,283 | 19.9 | 27,185 | 61.4 | ||||||||||||
| $ | 270,146 | 100.0 | % | $ | 222,789 | 100.0 | % | $ | 47,357 | 21.3 | % |
Geographic revenue information is based on the location to which we deliver our products and services.
The decrease in North America revenue for 2022 compared to 2021 was primarily due to decreased revenue from the Aerospace and Defense market, partially offset by increased revenue from the Industrial market. The decrease in China revenue for 2022 compared to 2021 was the result of decreased sales in the Industrial and Microfabrication markets, primarily as a result of deteriorating market conditions. The closure of our Shanghai facility for approximately two months during the second quarter of 2022 due to the COVID-19 pandemic also had a negative impact on 2022 sales in China. The increase in Rest of World revenue for 2022 compared to 2021 was due to increased revenue from the Microfabrication and Industrial markets.
The increase in North America revenue for 2021 compared to 2020 was primarily driven by increased revenue from the Aerospace and Defense and Industrials markets. The decrease in China revenue for 2021 compared to 2020 was due to decreased sales in the Industrial market as a result of deteriorating market conditions. The increase in Rest of World revenue for 2021 compared to 2020 was primarily due to increased sales in the Microfabrication and Industrial markets.
Cost of Revenues and Gross Margin
Cost of Laser Products revenue consists primarily of manufacturing materials, labor, shipping and handling costs, tariffs and manufacturing-related overhead. We order materials and supplies based on backlog and forecasted customer orders. We expense all warranty costs and inventory provisions as cost of revenues. Cost of Advanced Development revenue consists of materials, labor, subcontracting costs, an allocation of indirect costs including overhead and general and administrative.
Our gross profit and gross margin were as follows (dollars in thousands):
| Year Ended December 31, 2022 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Laser Products | Advanced Development | Corporate and Other | Total | |||||||||||
| Gross profit | $ | 50,063 | $ | 3,435 | $ | (2,677) | $ | 50,821 | ||||||
| Gross margin | 26.0 | % | 7.0 | % | NM* | 21.0 | % |
| Year Ended December 31, 2021 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Laser Products | Advanced Development | Corporate and Other | Total | |||||||||||
| Gross profit | $ | 75,833 | $ | 3,979 | $ | (2,505) | $ | 77,307 | ||||||
| Gross margin | 36.8 | % | 6.2 | % | NM* | 28.6 | % |
| Year Ended December 31, 2020 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Laser Products | Advanced Development | Corporate and Other | Total | |||||||||||
| Gross profit | $ | 58,207 | $ | 2,778 | $ | (1,621) | $ | 59,364 | ||||||
| Gross margin | 31.5 | % | 7.3 | % | NM* | 26.6 | % |
*NM - Not meaningful.
26
Table of Contents
The decrease in Laser Products gross margin for 2022 compared to 2021 was driven by sales mix, decreased factory utilization, increased labor and material costs, and increased freight costs, partially offset by an increase in duty reclaim. In addition, Laser Products gross margin in 2022 was negatively impacted by inventory charges related to business restructuring and the discontinuation of certain product lines in the fourth quarter of 2022. The increase in Advanced Development gross margin for 2022 compared to 2021 was not significant and was primarily the result of changes in the composition of research and development contracts.
The increase in Laser Products gross margin for 2021 compared to 2020 was primarily due to sales mix and improved factory utilization from higher production volume, offset partially by increases in manufacturing costs. The decrease in Advanced Development gross margin was driven primarily by changes in the composition of research and development contracts. Most of the Advanced Development segment revenue in 2021 was generated from cost plus fixed fee research and development contracts.
Operating Expenses
Our operating expenses were as follows (dollars in thousands):
Research and Development
| Year Ended December 31, | Change | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022 | 2021 | Amount | % | ||||||||||
| Research and development | $ | 53,773 | $ | 54,814 | $ | (1,041) | (1.9) |
| Year Ended December 31, | Change | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | 2020 | Amount | % | ||||||||||
| Research and development | $ | 54,814 | $ | 41,164 | $ | 13,650 | 33.2 |
The decrease in research and development expense for 2022 compared to 2021 was driven by a decrease in stock-based compensation of $1.8 million and a decrease in purchased intangible amortization of $1.2 million, partially offset by increases in salary costs and project-related expenses.
The increase in research and development expense for 2021 compared to 2020 was driven primarily by an increase in stock-based compensation costs of $3.7 million, and increased employee headcount and related costs, and project-related expenses, to support our development efforts.
Sales, General and Administrative
| Year Ended December 31, | Change | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022 | 2021 | Amount | % | ||||||||||
| Sales, general, and administrative | $ | 48,258 | $ | 52,710 | $ | (4,452) | (8.4) |
| Year Ended December 31, | Change | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | 2020 | Amount | % | ||||||||||
| Sales, general, and administrative | $ | 52,710 | $ | 39,248 | $ | 13,462 | 34.3 |
The decrease in sales, general and administrative expense for 2022 compared to 2021 was primarily due to a decrease in stock-based compensation of $9.4 million, partially offset by increases in salary costs, professional service fees and facility expenses, and a decrease in administrative costs allocated to development projects. The decrease in stock-based compensation was the result of forfeitures and decreases in expected achievement related to performance-based stock awards.
The increase in sales, general and administrative expense for 2021 compared to 2020 was primarily driven by an increase in stock-based compensation costs of $7.6 million, increased headcount and compensation costs, and increased professional fees.
27
Table of Contents
Restructuring
Restructuring in 2022 included the following (in thousands):
| Year Ended December 31, | ||
|---|---|---|
| 2022 | ||
| Employee termination costs | $ | 1,271 |
| Write-off of long-lived assets | 2,566 | |
| Other | 55 | |
| $ | 3,892 |
During the fourth quarter of 2022, we implemented a restructuring plan which included headcount reductions in both the U.S. and China, and the write-down of certain in-process capital equipment projects related to production capacity that were never completed or placed into service. There were no restructuring charges in 2021 or 2020.
Interest Income (Expense), net
Interest income (expense), net was as follows (in thousands):
| Year Ended December 31, | Change | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022 | 2021 | Amount | % | ||||||||||
| Interest income (expense), net | $ | 529 | $ | (163) | $ | 692 | 424.5 |
| Year Ended December 31, | Change | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | 2020 | Amount | % | ||||||||||
| Interest income (expense), net | $ | (163) | $ | 78 | $ | (241) | (309.0) |
The increase in net interest income for 2022 compared to 2021 was driven by increases in interest rates and the investment in marketable securities during the second quarter of 2022, as well as the payoff of our long-term debt in the third quarter of 2021.
The higher net interest expense for 2021 compared to 2020 was primarily attributable to an increase in bank charges and changes in the market rates on money market funds, offset partially by the March 2021 cash proceeds from our public offering of stock.
Other Income, net
| Year Ended December 31, | Change | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022 | 2021 | Amount | % | ||||||||||
| Other income, net | $ | 338 | $ | 336 | $ | 2 | 0.6 |
| Year Ended December 31, | Change | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | 2020 | Amount | % | ||||||||||
| Other income, net | $ | 336 | $ | 378 | $ | (42) | 11.1 |
The changes in other income, net, in 2022 compared to 2021, and 2021 compared to 2020, are primarily attributable to changes in net realized and unrealized foreign exchange transactions resulting from currency rate fluctuations.
28
Table of Contents
Income Tax Expense (Benefit)
| Year Ended December 31, | Change | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022 | 2021 | Amount | % | ||||||||||
| Income tax expense (benefit) | $ | 344 | $ | (375) | $ | 719 | 191.7 |
| Year Ended December 31, | Change | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | 2020 | Amount | % | ||||||||||
| Income tax expense (benefit) | $ | (375) | $ | 340 | $ | (715) | (210.3) |
We record income tax expense for taxes in our foreign jurisdictions including Finland, Italy, and South Korea. While our tax expense is largely dependent on the geographic mix of earnings related to our foreign operations, we also record tax expense for uncertain tax positions taken and associated penalties and interest. We consider all available evidence, both positive and negative, in assessing the extent to which a valuation allowance should be applied against our deferred tax assets. Due to the uncertainty with respect to their ultimate realizability in the United States, Austria, and China, we continue to maintain a full valuation allowance in these jurisdictions as of December 31, 2022. Our effective tax rate may vary from period to period based on changes in estimated taxable income or loss by jurisdiction, changes to the valuation allowance, changes to U.S. federal, state or foreign tax laws, future expansion into areas with varying country, state, and local income tax rates and deductibility of certain costs and expenses by jurisdiction.
The increase in income tax expense for 2022 compared to 2021 was driven by a discrete tax benefit related to return to provision true ups and expiring statutes of limitations of unrecognized tax positions recorded in the second quarter of 2021.
The tax benefit for 2021 was primarily related to the release of tax expense, interest and penalties associated with uncertain tax positions for which statutes of limitations have expired and prior year true ups in foreign jurisdictions. Our 2021 tax benefit was impacted by the geographic location of our pre-tax book income and was primarily related to our operations in Finland and foreign withholding taxes on undistributed earnings.
Liquidity and Capital Resources
We had cash and cash equivalents of $57.8 million and $146.5 million as of December 31, 2022 and 2021, respectively. In addition, we had marketable securities of $50.4 million as of December 31, 2022. Total cash, cash equivalents and marketable securities were $108.2 million as of December 31, 2022.
For the year ended December 31, 2022, our principal uses of liquidity were to fund operating activities, acquire plant and equipment and tax payments related to stock award issuances. The primary source of cash was collections from customers.
We believe our existing sources of liquidity will be sufficient to meet our working capital and capital expenditure needs for at least the next 12 months. Our future capital requirements may vary materially from period to period and will depend on many factors, including the timing and extent of spending on research and development efforts, the expansion of sales and marketing activities, the continuing market acceptance of our products and ongoing investments to support the growth of our business. We may in the future enter into arrangements to acquire or invest in complementary businesses, services, technologies and intellectual property rights. From time to time, we may explore additional financing sources which could include equity, equity‑linked and debt financing arrangements.
29
Table of Contents
The following table summarizes our cash flows for the periods presented (in thousands):
| Year Ended December 31, | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2022 | 2021 | 2020 | ||||||||
| Net cash (used in) provided by operating activities | $ | (14,542) | $ | (7,443) | $ | 13,041 | ||||
| Net cash used in investing activities | (72,381) | (21,853) | (24,539) | |||||||
| Net cash (used in) provided by financing activities | (1,306) | 73,742 | (3,767) | |||||||
| Effect of exchange rate changes on cash | (477) | (235) | 545 | |||||||
| Net increase (decrease) in cash, cash equivalents, and restricted cash | $ | (88,706) | $ | 44,211 | $ | (14,720) |
Net Cash (Used in) Provided by Operating Activities
During the year ended December 31, 2022, net cash used in operating activities was $14.5 million, which was the result of a $54.6 million net loss and use of cash for working capital of $8.2 million, offset partially by non‑cash expenses totaling $48.3 million related primarily to depreciation, amortization, and stock-based compensation. Changes in working capital were driven by a $5.9 million decrease in accounts payable and a $4.6 million decrease in inventory.
During the year ended December 31, 2021, net cash used in operating activities was $7.4 million, which was primarily driven by $29.7 million of net loss and use of cash for working capital of $33.7 million, partially offset by non-cash expenses totaling $56.0 million related to depreciation and amortization, stock-based compensation, and other items. Changes in working capital were driven by a $19.0 million increase in inventory, a $9.5 million increase in accounts receivable and a $3.6 million increase in prepaid expenses and other current assets.
Net Cash Used in Investing Activities
During the year ended December 31, 2022, net cash used in investing activities was $72.4 million, including the net purchase of $50.0 million of marketable securities and $21.4 million of capital expenditures related to investments in directed energy, manufacturing equipment and facilities.
During the year ended December 31, 2021, net cash used in investing activities was $21.9 million, including $19.3 million of capital expenditures related primarily to investments in manufacturing equipment and improvements to our corporate facility.
Net Cash (Used in) Provided by Financing Activities
During the year ended December 31, 2022, net cash used in financing activities was $1.3 million, which was primarily driven by $4.9 million of withholding tax payments related to the vesting of stock awards, partially offset by $3.6 million of proceeds from stock options exercises and employee stock plan purchases.
During the year ended December 31, 2021, net cash provided by financing activities was $73.7 million, which was primarily driven by our follow-on public offering of $82.4 million, net of offering costs, and $2.7 million of proceeds from stock options exercised and employee stock plan purchases, partially offset by $10.6 million of withholding tax payments related to vesting of restricted stock awards.
Credit Facilities
We have a $40.0 million revolving line of credit, or LOC, with Pacific Western Bank dated September 24, 2018, which is secured by our assets and expires September 24, 2024.
The LOC agreement contains restrictive and financial covenants and bears an unused credit fee of 0.20% on an annualized basis. The interest rate on the LOC is based on the Prime rate, minus a margin based on our liquidity levels. No amounts were outstanding under the LOC at December 31, 2022 and 2021 and we were in compliance with all covenants.
30
Table of Contents
Contractual Obligations
The following table sets forth a summary of our significant contractual obligations to make future payments in cash as of December 31, 2022 (in thousands):
| Payments Due by Year | ||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | 2024 | 2025 | 2026 | 2027 | Thereafter | Total | ||||||||||||||||||||
| Purchase commitments | $ | 47,308 | $ | — | $ | — | $ | — | $ | — | $ | — | $ | 47,308 | ||||||||||||
| Lease obligations | 3,235 | 2,848 | 2,037 | 1,654 | 1,655 | 6,806 | 18,235 | |||||||||||||||||||
| Total | $ | 50,543 | $ | 2,848 | $ | 2,037 | $ | 1,654 | $ | 1,655 | $ | 6,806 | $ | 65,543 |
Critical Accounting Policies and Significant Estimates
Our discussion and analysis of our financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with generally accepted accounting principles in the United States of America (GAAP). The preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of net revenue and expenses in the reporting period. Our accounting policies are fundamental to understanding our financial condition and results of operations reported in our financial statements and related disclosures. We have identified the following accounting policies as being critical because they require our management to make particularly difficult, subjective and/or complex judgments about the effect of matters that are inherently uncertain.
Revenue Recognition
We recognize revenue upon transferring control of products and services and the amounts recognized reflect the consideration we expect to be entitled to receive in exchange for these products and services. We consider customer purchase orders, which in some cases are governed by master sales agreements, to be the contracts with a customer. As part of our consideration of the contract, we evaluate certain factors, including the customer's ability to pay (or credit risk). For each contract, we consider the promise to transfer products, each of which is distinct, as the identified performance obligations.
We allocate the transaction price to each distinct product based on its relative standalone selling price. Master sales agreements or purchase orders from customers could include a single product or multiple products. Regardless, the contracted price with the customer is agreed to at the individual product level outlined in the customer contract or purchase order. We do not bundle prices; however, we do negotiate with customers on pricing for the same products based on a variety of factors (e.g., level of contractual volume). We have concluded that the prices negotiated with each individual customer are representative of the stand-alone selling price of the product.
We often receive orders with multiple delivery dates that may extend across several reporting periods. We allocate the transaction price of the contract to each delivery based on the product standalone selling price and invoice for each scheduled delivery upon shipment or delivery and recognize revenues for such delivery at the point when transfer of control has occurred. As scheduled delivery dates are generally within one year, under the optional exemption provided by ASC 606-10-50-14a revenues allocated to future shipments of partially completed contracts are not disclosed as performance obligations for point in time revenue. Further, the Company recognizes over time revenue as per ASC 606-10-55-18 (invoice practical expedient) for its cost plus contracts and, accordingly, elects not to disclose information related to those performance obligations under ASC 606-10-50-14b.
Rights of return generally are not included in customer contracts. Accordingly, product revenue is recognized upon transfer of control at shipment or delivery, as applicable. Rights of return are evaluated as they occur.
Revenues recognized at a point in time consist of sales of semiconductor lasers, fiber lasers and other related products. Revenues recognized over time generally consist of development arrangements that are structured based on our costs incurred. Because control transfers over time, revenue is recognized based on the extent of progress towards completion of the performance obligation. We generally use the cost-to-cost measure of progress for our contracts because it best depicts the transfer of control to the customer. Billing under these arrangements generally occurs within one month after the work is completed.
Inventory Valuation
Inventory is stated at the lower of average cost (principally standard cost, which approximates actual cost on a first-in, first-out basis) and net realizable value. Inventory includes raw materials and components that may be specialized in nature and subject to obsolescence. On a quarterly basis, we review inventory quantities on hand in comparison to our past consumption, recent purchases, and other factors to determine what inventory quantities, if
31
Table of Contents
any, may not be sellable. Based on this analysis, we write down the affected inventory value for estimated excess and obsolescence charges. At the point of loss recognition, a new, lower-cost basis for that inventory is established, and subsequent changes in facts and circumstances do not result in the restoration or increase in that newly established cost basis.
Inflation
While we do not believe that inflation had a material effect on our business, financial condition or results of operations during the year ended December 31, 2022, we experienced higher than expected increases in wages and other compensation costs, materials, and shipping costs during 2022. We expect these increases will continue to impact our cost structure. If our costs become subject to significant inflationary pressures, we may not be able to fully offset such higher costs through price increases. Our inability or failure to do so could materially adversely affect our business, financial condition and results of operations.
Recent Accounting Pronouncements
See Note 1 of Notes to Consolidated Financial Statements.
FY 2021 10-K MD&A
SEC filing source: 0001124796-22-000028.
ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
21
Table of Contents
SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
This Annual Report on Form 10-K contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In some cases, you can identify forward-looking statements by the following words: "ability," "anticipate," "attempt," "believe," "can be," "continue," "could," "depend," "enable," "estimate," "expect," "extend," "grow," "if," "intend," "likely," "may," "objective," "ongoing," "plan," "possible," "potential," "predict," "project," "propose," "rely," "should," "target," "will," "would" or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words.
These statements involve risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from the information expressed or implied by these forward-looking statements. Although we believe that we have a reasonable basis for each forward-looking statement, we caution you that these statements are based on a combination of facts and factors currently known by us and our projections of the future, about which we cannot be certain. Forward-looking statements include, but are not limited to, statements about: our ability to develop innovative products; the implementation of our business model and strategic plans, including estimates regarding expenses and capital requirements; our competition and our ability to successfully compete; the impact of the COVID-19 pandemic on our business; demand for our semiconductor and fiber laser solutions; our technology and new product research and development activities; our ability to source key components and raw materials from our suppliers; the impact of inflation; our future financial performance; our utilization of vertical integration; our ability to adequately protect our intellectual property rights; the effect on our business of litigation to which we are or may become a party; and the sufficiency of our existing liquidity sources to meet our cash needs.
You should refer to the "Risk Factors" section of this report for a discussion of other important factors that may cause our actual results to differ materially from those expressed or implied by our forward-looking statements. As a result of these factors, we cannot assure you that the forward-looking statements in this report will prove to be accurate. In addition, statements that "we believe" and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based upon information available to us as of the date of this report, which although we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete, and our statements should not be read to indicate that we have conducted a thorough inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain and investors are cautioned not to unduly rely upon these statements. Furthermore, if our forward-looking statements prove to be inaccurate, the inaccuracy may be material. In light of the significant uncertainties in these forward-looking statements, you should not regard these statements as a representation or warranty by us or any other person that we will achieve our objectives and plans in any specified time frame, or at all. We undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
Overview
nLIGHT, Inc., is a leading provider of high‑power semiconductor and fiber lasers for industrial, microfabrication, and aerospace and defense applications. Headquartered in Camas, Washington, we design, develop and manufacture the critical elements of our lasers, and believe our vertically integrated business model enables us to rapidly introduce innovative products, control our costs and protect our intellectual property.
We operate in two reportable segments consisting of the Laser Products segment and the Advanced Development segment. Sales of our semiconductor lasers, fiber lasers and directed energy products are included in the Laser Products segment, while revenue earned from research and development contracts are included in the Advanced Development segment.
Revenues increased to $270.1 million in the year ended December 31, 2021 compared to $222.8 million in the same period of 2020 as a result of higher revenue across all end markets. We generated a net loss of $29.7 million for the year ended December 31, 2021 compared to a net loss of $20.9 million for the same period of 2020, primarily as a result of a $12.3 million increase in stock-based compensation.
22
Table of Contents
Factors Affecting Our Performance
Impact of the COVID-19 Pandemic
The COVID-19 pandemic and related global liquidity concerns and significant macro-economic volatility continues to adversely impact our end-markets, including reduced economic activity and demand for our products, delays in new capital expenditure decisions and implementations, and restrictions on individual and business activities and travel. While our global manufacturing operations have generally remained open throughout the pandemic, including our manufacturing facilities in the United States which are considered essential businesses, we have previously been affected by the temporary closure of our Shanghai manufacturing facility due to government-imposed restrictions. Some of our non-manufacturing and technical service personnel have been partially working from home since March 2020. In recent periods, labor issues have also become more pronounced as a result of the COVID-19 pandemic and we have experienced higher than expected increases in wages and other compensation costs as well as increased competition for qualified employees.
There are ongoing related risks to our business depending on the progression of the COVID-19 pandemic, including from the potential returns to limited or closed government functions, business activities and person-to-person interactions. Global trade conditions may further adversely impact us and our industry. For example, pandemic-related issues have exacerbated port congestion and caused intermittent supplier shutdowns and delays, resulting in additional expenses and challenges to obtaining critical parts. The full impact of the COVID-19 pandemic on our financial condition and results of operations will depend on future events and developments, such as the duration and magnitude of the pandemic and the conditions and timing under which restrictions will be lifted or re-imposed, impacts on our supply and distribution chains as well as our customers, the demand for our products and whether the pandemic leads to recessionary conditions in any of our key markets.
Demand for our Semiconductor and Fiber Laser Solutions
In order to continue to grow our revenues, we must continue to achieve design wins for our semiconductor and fiber lasers. We consider a design win to occur when a customer notifies us that it has selected one of our products to be incorporated into a product or system under development by such customer. For the foreseeable future, our operations will continue to depend upon capital expenditures by customers in the Industrial and Microfabrication markets, which, in turn, depend upon the demand for these customers’ products or services. In addition, in the Aerospace and Defense market, our business depends in large part on continued investment in laser technology by the U.S. government and its allies, and our ability to continue to successfully develop leading technology in this area and commercialize that technology in the future.
Demand for our products also fluctuates based on market cycles, continuously evolving industry supply chains, trade and tariff terms, as well as evolving competitive dynamics in each of our end-markets. Erosion of average selling prices, or ASPs, of established products is typical in our industry, and the ASPs of our products generally decrease as our products mature. We may also negotiate discounted selling prices from time to time with certain customers that purchase higher volumes, or to penetrate new markets or applications. Historically, we have been able to offset decreasing ASPs by introducing new and higher value products, increasing the sales of our existing products, expanding into new applications and reducing our manufacturing costs. Although we anticipate further increases in product volumes and the continued introduction of new and higher value products, ASP reduction may cause our revenues to decline or grow at a slower rate.
Technology and New Product Development
We invest heavily in the development of our semiconductor, fiber laser and directed energy technologies to provide solutions to our current and future customers. We anticipate that we will continue to invest in research and development to achieve our technology and product roadmap. Our product development is targeted to specific sectors of the market where we believe the power and performance requirements of our products can provide the most benefit. We believe our close coordination with our customers regarding their future product requirements enhances the efficiency of our research and development expenditures.
23
Table of Contents
Manufacturing Costs and Gross Margins
Our Product gross profit, in absolute dollars and as a percentage of revenues, is impacted by our product sales mix, sales volumes, changes in ASPs, production volumes, the corresponding absorption of manufacturing overhead expenses, production costs and manufacturing yields. Our product sales mix can affect gross profits due to variations in profitability related to product- configurations and cost profiles, customer volume pricing, availability of competitive products in various markets, and new product introductions, among other factors. Capacity utilization affects our gross margin because we have a high fixed cost base due to our vertically integrated business model. Increases in sales and production volumes drive favorable absorption of fixed costs, improved manufacturing efficiencies and lower production costs. Gross margins may fluctuate from period to period depending on product mix and the level of capacity utilization.
Our Development gross profit varies with the type and terms of contracts, contract volume, project mix, and progress on projects during the period. Most of our Development contracts are structured as cost plus fixed fee due to the technical complexity of the research and development services.
Seasonality
Our quarterly revenues can fluctuate with general economic trends, holidays in foreign countries such as Chinese New Year in the first quarter of our fiscal year, the timing of capital expenditures by our customers, and general economic trends. In addition, as is typical in our industry, we tend to recognize a larger percentage of our quarterly revenues in the last month of the quarter, which may impact our working capital trends.
Results of Operations
The following table sets forth our operating results as a percentage of revenues for the periods indicated (which may not add up due to rounding):
| Year Ended December 31, | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | 2020 | 2019 | |||||||||
| Revenue: | |||||||||||
| Products | 76.3 | % | 83.0 | % | 98.6 | % | |||||
| Development | 23.7 | 17.0 | 1.4 | ||||||||
| Total revenue | 100.0 | 100.0 | 100.0 | ||||||||
| Cost of revenue: | |||||||||||
| Products | 49.2 | 57.6 | 69.1 | ||||||||
| Development | 22.2 | 15.8 | 1.3 | ||||||||
| Total cost of revenue | 71.4 | 73.4 | 70.4 | ||||||||
| Gross profit | 28.6 | 26.6 | 29.6 | ||||||||
| Operating expenses: | |||||||||||
| Research and development | 20.3 | 18.5 | 15.9 | ||||||||
| Sales, general and administrative | 19.5 | 17.6 | 19.3 | ||||||||
| Total operating expenses | 39.8 | 36.1 | 35.2 | ||||||||
| Loss from operations | (11.2) | (9.4) | (5.6) | ||||||||
| Other income (expense): | |||||||||||
| Interest income (expense), net | (0.1) | — | 1.5 | ||||||||
| Other income, net | 0.1 | 0.2 | 0.3 | ||||||||
| Loss before income taxes | (11.2) | (9.2) | (3.8) | ||||||||
| Income tax expense (benefit) | (0.1) | 0.2 | 3.5 | ||||||||
| Net loss | (11.1) | % | (9.4) | % | (7.3) | % |
Revenues by End Market
Our revenues by end market were as follows for the periods presented (dollars in thousands):
24
Table of Contents
| Year Ended December 31, | Change | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | % of Revenue | 2020 | % of Revenue | Amount | % | |||||||||||||
| Industrial | $ | 94,795 | 35.1 | % | $ | 84,478 | 37.9 | % | $ | 10,317 | 12.2 | % | ||||||
| Microfabrication | 70,412 | 26.1 | 51,649 | 23.2 | 18,763 | 36.3 | ||||||||||||
| Aerospace and Defense | 104,939 | 38.8 | 86,662 | 38.9 | 18,277 | 21.1 | ||||||||||||
| $ | 270,146 | 100.0 | % | $ | 222,789 | 100.0 | % | $ | 47,357 | 21.3 | % |
| Year Ended December 31, | Change | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020 | % of Revenue | 2019 | % of Revenue | Amount | % | |||||||||||||
| Industrial | $ | 84,478 | 37.9 | % | $ | 76,668 | 43.4 | % | $ | 7,810 | 10.2 | % | ||||||
| Microfabrication | 51,649 | 23.2 | 57,153 | 32.4 | (5,504) | (9.6) | ||||||||||||
| Aerospace and Defense | 86,662 | 38.9 | 42,798 | 24.2 | 43,864 | 102.5 | ||||||||||||
| $ | 222,789 | 100.0 | % | $ | 176,619 | 100.0 | % | $ | 46,170 | 26.1 | % |
The increase in Industrial market revenue for 2021 compared to 2020 was driven by increases in unit sales outside of China, partially offset by a decrease in unit sales in China and lower average selling prices due to changes in product mix. The increase in unit sales outside of China was driven by increased customer demand for fiber lasers used in cutting applications and new products for additive manufacturing, while the decrease in unit sales in China was the result of increased competitive pressure and declining sales prices for fiber lasers used in cutting applications. The increase in Microfabrication market revenue for 2021 compared to 2020 was attributable to increases in customer demand and unit sales of semiconductor lasers. The increase in Aerospace and Defense market revenue for 2021 compared to 2020 was primarily due to increased activity on existing research and development contracts, offset partially by a decrease in product sales.
The increase in Industrial market revenue for 2020 compared to 2019 was driven by increased unit sales and changes in sales mix towards high-power fiber lasers. The decrease in Microfabrication market revenue for 2020 compared to 2019 was driven primarily by lower unit sales to customers for consumer electronics and semiconductors. The increase in Aerospace and Defense market revenue for 2020 compared to 2019 was primarily due to the acquisition of Nutronics, and an increase in unit sales to new and existing customers for defense applications.
Revenues by Segment
Our revenues by segment were as follows for the periods presented (dollars in thousands):
| Year Ended December 31, | Change | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | % of Revenue | 2020 | % of Revenue | Amount | % | |||||||||||||
| Laser Products | $ | 206,195 | 76.3 | % | $ | 184,841 | 83.0 | % | $ | 21,354 | 11.6 | % | ||||||
| Advanced Development | 63,951 | 23.7 | 37,948 | 17.0 | 26,003 | 68.5 | ||||||||||||
| $ | 270,146 | 100.0 | % | $ | 222,789 | 100.0 | % | $ | 47,357 | 21.3 | % |
| Year Ended December 31, | Change | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020 | % of Revenue | 2019 | % of Revenue | Amount | % | |||||||||||||
| Laser Products | $ | 184,841 | 83.0 | % | $ | 174,059 | 98.6 | % | $ | 10,782 | 6.2 | % | ||||||
| Advanced Development | 37,948 | 17.0 | 2,560 | 1.4 | 35,388 | NM | ||||||||||||
| $ | 222,789 | 100.0 | % | $ | 176,619 | 100.0 | % | $ | 46,170 | 26.1 | % |
The increase in Laser Products revenue for 2021 compared to 2020 was primarily due to higher revenue and demand from the Industrial and Microfabrication markets outside of China, offset partially by a decrease in product sales to the Aerospace and Defense market. The increase in Advanced Development revenue for 2021 compared to 2020 was driven by increased activity on existing research and development contracts with the U.S. Government.
25
Table of Contents
The increase in Laser Products revenue for 2020 compared to 2019 was driven by higher revenue and demand from the Industrial and Aerospace and Defense markets, offset partially by lower revenue from the Microfabrication market. The increase in Advanced Development revenue for 2020 compared to 2019 was primarily due to the acquisition of Nutronics in November 2019.
Revenues by Geographic Region
Our revenues by geographic region were as follows for the periods presented (dollars in thousands):
| Year Ended December 31, | Change | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | % of Revenue | 2020 | % of Revenue | Amount | % | |||||||||||||
| North America | $ | 143,232 | 53.0 | % | $ | 107,624 | 48.3 | % | $ | 35,608 | 33.1 | % | ||||||
| China | 55,446 | 20.5 | 70,882 | 31.8 | (15,436) | (21.8) | ||||||||||||
| Rest of World | 71,468 | 26.5 | 44,283 | 19.9 | 27,185 | 61.4 | ||||||||||||
| $ | 270,146 | 100.0 | % | $ | 222,789 | 100.0 | % | $ | 47,357 | 21.3 | % |
| Year Ended December 31, | Change | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020 | % of Revenue | 2019 | % of Revenue | Amount | % | |||||||||||||
| North America | $ | 107,624 | 48.3 | % | $ | 67,511 | 38.2 | % | $ | 40,113 | 59.4 | % | ||||||
| China | 70,882 | 31.8 | 64,134 | 36.3 | 6,748 | 10.5 | ||||||||||||
| Rest of World | 44,283 | 19.9 | 44,974 | 25.5 | (691) | (1.5) | ||||||||||||
| $ | 222,789 | 100.0 | % | $ | 176,619 | 100.0 | % | $ | 46,170 | 26.1 | % |
Geographic revenue information is based on the location to which we deliver our products and services. The increase in North America revenue for 2021 compared to 2020 was primarily driven by increased revenue from the Aerospace and Defense and Industrials markets. The decrease in China revenue for 2021 compared to 2020 was due to decreased sales in the Industrial market as a result of deteriorating market conditions. The increase in Rest of World revenue for 2021 compared to 2020 was primarily due to increased sales in the Microfabrication and Industrial markets.
The increase in North America revenue for 2020 compared to 2019 was primarily driven by the acquisition of Nutronics and increased sales in the Aerospace and Defense market, partially offset by decreased sales in the Microfabrication market. The increase in China revenue for 2020 compared to 2019 was primarily due to increased sales in the Industrial market. There was no significant change in Rest of World revenue for 2020 compared to 2019.
Cost of Revenues and Gross Margin
Cost of Laser Products revenue consists primarily of manufacturing materials, labor, shipping and handling costs, tariffs and manufacturing-related overhead. We order materials and supplies based on backlog and forecasted customer orders. We expense all warranty costs and inventory provisions as cost of revenues. Cost of Advanced Development revenue consists of materials, labor, subcontracting costs, an allocation of indirect costs including overhead and general and administrative.
Our gross profit and gross margin were as follows for the periods presented (dollars in thousands):
| Year Ended December 31, 2021 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Laser Products | Advanced Development | Corporate and Other | Total | |||||||||||
| Gross profit | $ | 75,833 | $ | 3,979 | $ | (2,505) | $ | 77,307 | ||||||
| Gross margin | 36.8 | % | 6.2 | % | NM | 28.6 | % |
26
Table of Contents
| Year Ended December 31, 2020 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Laser Products | Advanced Development | Corporate and Other | Total | |||||||||||
| Gross profit | $ | 58,207 | $ | 2,778 | $ | (1,621) | $ | 59,364 | ||||||
| Gross margin | 31.5 | % | 7.3 | % | NM | 26.6 | % |
| Year Ended December 31, 2019 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Laser Products | Advanced Development | Corporate and Other | Total | |||||||||||
| Gross profit | $ | 53,247 | $ | 293 | $ | (1,201) | $ | 52,339 | ||||||
| Gross margin | 30.6 | % | 11.4 | % | NM | 29.6 | % |
The increase in Laser Products gross margin for 2021 compared to 2020 was primarily due to sales mix and improved factory utilization from higher production volume, offset partially by increases in manufacturing costs. The decrease in Advanced Development gross margin was driven primarily by changes in the composition of research and development contracts. Most of the Advanced Development segment revenue in 2021 was generated from cost plus fixed fee research and development contracts.
The increase in Laser Products gross margin for 2020 compared to 2019 was primarily due to product cost improvements, higher production volume and factory utilization, and lower import duty costs, offset partially by overall price reductions in the Industrial market, increased reserve charges, and changes in sales mix. Changes in Advanced Development gross margin are driven by changes in project mix since the acquisition of Nutronics in November 2019. Most of the Advanced Development segment revenue in 2020 was generated from cost plus fixed fee research and development projects.
Operating Expenses
Our operating expenses were as follows for the periods presented (dollars in thousands):
Research and Development
| Year Ended December 31, | Change | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | 2020 | Amount | % | ||||||||||
| Research and development | $ | 54,814 | $ | 41,164 | $ | 13,650 | 33.2 |
| Year Ended December 31, | Change | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020 | 2019 | Amount | % | ||||||||||
| Research and development | $ | 41,164 | $ | 28,137 | $ | 13,027 | 46.3 |
The increase in research and development expense for 2021 compared to 2020 was driven primarily by an increase in stock-based compensation costs of $3.7 million, and increased employee headcount and related costs, and project-related expenses, to support our development efforts.
The increase in research and development expense for 2020 compared to 2019 was driven primarily by increases in stock-based compensation costs of $6.4 million and purchased intangible amortization of $2.4 million from the Nutronics and OPI acquisitions in November 2019 and July 2020, respectively, and increased project-related expenses to support our development efforts.
Sales, General and Administrative
| Year Ended December 31, | Change | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | 2020 | Amount | % | ||||||||||
| Sales, general, and administrative | $ | 52,710 | $ | 39,248 | $ | 13,462 | 34.3 |
27
Table of Contents
| Year Ended December 31, | Change | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020 | 2019 | Amount | % | ||||||||||
| Sales, general, and administrative | $ | 39,248 | $ | 34,111 | $ | 5,137 | 15.1 |
The increase in sales, general and administrative expense for 2021 compared to 2020 was primarily driven by an increase in stock-based compensation costs of $7.6 million, increased headcount and compensation costs, and increased professional fees.
The increase in sales, general and administrative expense for 2020 compared to 2019 was primarily driven by an increase in stock-based compensation costs of $8.9 million, partially offset by a decrease in executive cash compensation, lower professional fees and decreased marketing and travel costs due to COVID-19.
Interest Income, net
| Year Ended December 31, | Change | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | 2020 | Amount | % | ||||||||||
| Interest income (expense), net | $ | (163) | $ | 78 | $ | (241) | (309.0) |
| Year Ended December 31, | Change | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020 | 2019 | Amount | % | ||||||||||
| Interest income, net | $ | 78 | $ | 2,609 | $ | (2,531) | (97.0) |
The decrease in interest income (expense), net, for 2021 compared to 2020 was primarily attributable to an increase in bank charges and changes in the market rates on money market funds, offset partially by the March 2021 cash infusion from our public offering of stock.
The decrease in interest income, net, for 2020 compared to 2019 was primarily attributable to lower balances in our money market funds coupled with a decrease in the market rates on those funds.
Other Income (Expense), net
| Year Ended December 31, | Change | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | 2020 | Amount | % | ||||||||||
| Other income, net | $ | 336 | $ | 378 | $ | (42) | (11.1) |
| Year Ended December 31, | Change | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020 | 2019 | Amount | % | ||||||||||
| Other income, net | $ | 378 | $ | 535 | $ | (157) | 29.3 |
The changes in other income, net, in 2021 compared to 2020, and 2020 compared to 2019, are primarily attributable to changes in net realized and unrealized foreign exchange transactions resulting from currency rate fluctuations.
Income Tax Expense (Benefit)
| Year Ended December 31, | Change | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | 2020 | Amount | % | ||||||||||
| Income tax expense (benefit) | $ | (375) | $ | 340 | $ | (715) | (210.3) |
| Year Ended December 31, | Change | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020 | 2019 | Amount | % | ||||||||||
| Income tax expense | $ | 340 | $ | 6,119 | $ | (5,779) | (94.4) |
28
Table of Contents
The decrease in tax expense to a net benefit for 2021 compared to 2020 was primarily related to the release of tax expense, interest and penalties associated with uncertain tax positions for which statutes of limitations have expired and prior year true ups in foreign jurisdictions. Our 2021 tax benefit was impacted by the geographic location of our pre-tax book income and was primarily related to our operations in Finland and foreign withholding taxes on undistributed earnings. There is limited tax expense associated with our operations in the U.S. and China as we maintain a full valuation allowance against our U.S. and China deferred tax assets. Our effective tax rate may vary from period to period based on changes in estimated taxable income or loss by jurisdiction, changes to the valuation allowance, changes to U.S. federal, state or foreign tax laws, future expansion into areas with varying country, state, and local income tax rates and deductibility of certain costs and expenses by jurisdiction.
The decrease in tax expense for 2020 compared to 2019 was primarily related to recording a valuation allowance against our China deferred tax assets due to uncertainty with respect to their ultimate realizability in 2019, offset partially in 2020 by changes in the mix of earnings by tax jurisdiction, and the recording of a purchase accounting adjustment in 2019 related to not making a tax election to treat the Nutronics share purchase as an asset purchase for tax purposes.
Liquidity and Capital Resources
We had cash and cash equivalents of $146.5 million and $102.3 million as of December 31, 2021 and 2020, respectively.
For the year ended December 31, 2021, our principal uses of liquidity were to fund operating activities, acquire plant and equipment and tax payments related to stock award issuances. The primary source of cash was our public offering in March 2021.
We believe our existing sources of liquidity will be sufficient to meet our working capital and capital expenditure needs for at least the next 12 months. However, we may raise additional capital to expand the commercialization of our products, fund our operations, further our research and development activities or for other corporate purposes. Our future capital requirements may vary materially from period to period and will depend on many factors, including the timing and extent of spending on research and development efforts, the expansion of sales and marketing activities, the continuing market acceptance of our products and ongoing investments to support the growth of our business. We may in the future enter into arrangements to acquire or invest in complementary businesses, services, technologies and intellectual property rights. From time to time, we may explore additional financing sources which could include equity, equity‑linked and debt financing arrangements.
The following table summarizes our cash flows for the periods presented (in thousands):
| Year Ended December 31, | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | 2020 | 2019 | ||||||||
| Net cash provided by (used in) operating activities | $ | (7,443) | $ | 13,041 | $ | (4,241) | ||||
| Net cash used in investing activities | (21,853) | (24,539) | (30,404) | |||||||
| Net cash provided by (used in) financing activities | 73,742 | (3,767) | 2,452 | |||||||
| Effect of exchange rate changes on cash | (235) | 545 | (33) | |||||||
| Net increase (decrease) in cash | $ | 44,211 | $ | (14,720) | $ | (32,226) |
Net Cash Provided by (Used in) Operating Activities
During the year ended December 31, 2021, net cash used in operating activities was $7.4 million, which was the result of a $29.7 million net loss and use of cash for working capital of $33.7 million, offset partially by non‑cash expenses totaling $56.0 million related primarily to depreciation, amortization, and stock-based compensation. Changes in working capital were driven by a $19.0 million increase in inventory, a $9.5 million increase in accounts receivable, and a $3.6 million increase in prepaid expenses and other current assets.
The increase in inventory was driven primarily by an increase in safety stock to address risks related to the supply chain, logistics, and manufacturing disruptions, and to support new product introductions. The increase in accounts receivable was attributable to the timing of shipments and increases in revenue, and the increase in prepaid expenses and other current assets was attributable to an increase in contract assets.
29
Table of Contents
During the year ended December 31, 2020, net cash provided by operating activities was $13.0 million, which was primarily driven by $20.9 million of net loss reported for the period, and non-cash adjustments of $42.1 million related to depreciation and amortization, stock-based compensation, and other items. These items were partially offset by a $6.9 million increase in inventory and changes in other operating assets and liabilities. The increase in inventory supported new product introductions, decreased customer lead times and increased safety stock.
Net Cash Used in Investing Activities
During the year ended December 31, 2021, net cash used in investing activities was $21.9 million, including $19.3 million of capital expenditures related primarily to investments in manufacturing equipment and improvements to our corporate facility.
During the year ended December 31, 2020, net cash used in investing activities was $24.5 million, primarily resulting from $23.4 million of capital expenditures related to the acquisition of commercial property in Camas, Washington, and other investments in manufacturing equipment for our worldwide operations.
Net Cash Provided by (Used in) Financing Activities
During the year ended December 31, 2021, net cash provided by financing activities was $73.7 million, which was primarily driven by our follow-on public offering of $82.4 million, net of offering costs, and $2.7 million of proceeds from stock options exercised and employee stock plan purchases, partially offset by $10.6 million of withholding tax payments related to vesting of restricted stock awards.
During the year ended December 31, 2020, net cash used in financing activities was $3.8 million, which was primarily driven by $6.4 million of withholding tax payments related to vesting of restricted stock awards, offset by $2.8 million of proceeds from stock options exercises and employee stock program purchases. In addition, the $15.0 million in proceeds from our revolving line of credit drawn in the first quarter of 2020 was paid in full during the third quarter of 2020.
Credit Facilities
We have a $40.0 million revolving line of credit, or LOC, with Pacific Western Bank dated September 24, 2018, which is secured by our assets.
On September 24, 2021, we amended the LOC to extend the maturity date to September 24, 2024, remove LIBOR references and update the financial covenants.
The LOC agreement contains restrictive and financial covenants and bears an unused credit fee of 0.20% on an annualized basis. The interest rate on the LOC is based on the Prime rate, minus a margin based on our liquidity levels. No amounts were outstanding under the LOC at December 31, 2021 and 2020 and we were in compliance with all covenants.
Contractual Obligations
The following table sets forth a summary of our significant contractual obligations to make future payments in cash as of December 31, 2021 (in thousands):
| Payments Due by Year | ||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022 | 2023 | 2024 | 2025 | 2026 | Thereafter | Total | ||||||||||||||||||||
| Purchase commitments | $ | 68,831 | $ | 1,414 | $ | — | $ | — | $ | — | $ | — | $ | 70,245 | ||||||||||||
| Lease obligations | 3,640 | 2,804 | 2,421 | 1,912 | 1,617 | 8,424 | 20,818 | |||||||||||||||||||
| Total | $ | 72,471 | $ | 4,218 | $ | 2,421 | $ | 1,912 | $ | 1,617 | $ | 8,424 | $ | 91,063 |
Critical Accounting Policies and Significant Estimates
Our critical accounting policies consist of policies relating to revenue recognition and inventory. See Notes 1, 3 and 7 of Notes to Consolidated Financial Statements for detailed discussions of our critical accounting policies and significant estimates.
30
Table of Contents
Inflation
While we do not believe that inflation had a material effect on our business, financial condition or results of operations through December 31, 2021, we experienced higher than expected increases in wages and other compensation costs, as well as increased shipping costs, during 2021, which is a trend we expect to continue in the near term. We expect those increases will continue to impact our cost structure. If our costs become subject to significant inflationary pressures, we may not be able to fully offset such higher costs through price increases. Our inability or failure to do so could materially adversely affect our business, financial condition and results of operations.
Recent Accounting Pronouncements
See Note 1 of Notes to Consolidated Financial Statements.